Grf40	B-protein
,	O
A	O
novel	O
Grb2	B-protein
family	I-protein
member	I-protein
,	O
is	O
involved	O
in	O
T	O
cell	O
signaling	O
through	O
interaction	O
with	O
SLP-76	B-protein
and	O
LAT	B-protein
.	O

We	O
molecularly	O
cloned	O
a	O
new	O
Grb2	B-protein
family	I-protein
member	I-protein
,	O
named	O
Grf40	B-protein
,	O
containing	O
the	O
common	O
SH3-SH2-SH3	B-protein
motif	I-protein
.	O

Expression	O
of	O
Grf40	B-protein
is	O
predominant	O
in	O
hematopoietic	B-cell_type
cells	I-cell_type
,	O
particularly	O
T	B-cell_type
cells	I-cell_type
.	O

Grf40	B-protein
binds	O
to	O
the	O
SH2	B-protein
domain-containing	I-protein
leukocyte	I-protein
protein	I-protein
of	O
76	O
kD	O
(	O
SLP-76	B-protein
)	O
via	O
its	O
SH3	O
domain	O
more	O
tightly	O
than	O
Grb2	B-protein
.	O

Incidentally	O
,	O
Grf40	B-protein
binds	O
to	O
linker	B-protein
for	I-protein
activation	I-protein
of	I-protein
T	I-protein
cells	I-protein
(	O
LAT	B-protein
)	O
possibly	O
via	O
its	O
SH2	B-protein
domain	I-protein
.	O

Overexpression	O
of	O
wild-type	B-protein
Grf40	I-protein
in	O
Jurkat	B-cell_line
cells	I-cell_line
induced	O
a	O
significant	O
increase	O
of	O
SLP-76-dependent	B-DNA
interleukin	I-DNA
(	I-DNA
IL	I-DNA
)	I-DNA
-2	I-DNA
promoter	I-DNA
and	O
nuclear	B-protein
factor	I-protein
of	I-protein
activated	I-protein
T	I-protein
cell	I-protein
(	O
NF-AT	B-protein
)	O
activation	O
upon	O
T	B-protein
cell	I-protein
receptor	I-protein
(	O
TCR	B-protein
)	O
stimulation	O
,	O
whereas	O
the	O
COOH-terminal	B-protein
SH3-deleted	I-protein
Grf40	I-protein
mutant	I-protein
lacked	O
any	O
recognizable	O
increase	O
in	O
IL-2	B-DNA
promoter	I-DNA
activity	O
.	O

Furthermore	O
,	O
the	O
SH2-deleted	B-protein
Grf40	I-protein
mutant	I-protein
led	O
to	O
a	O
marked	O
inhibition	O
of	O
these	O
regulatory	O
activities	O
,	O
the	O
effect	O
of	O
which	O
is	O
apparently	O
stronger	O
than	O
that	O
of	O
the	O
SH2-deleted	B-protein
Grb2	I-protein
mutant	I-protein
.	O

Our	O
data	O
suggest	O
that	O
Grf40	B-protein
is	O
an	O
adaptor	B-protein
molecule	I-protein
involved	O
in	O
TCR	B-protein
-mediated	O
signaling	O
through	O
a	O
more	O
efficient	O
interaction	O
than	O
Grb2	B-protein
with	O
SLP-76	B-protein
and	O
LAT	B-protein
.	O

Grf40	NULL
,	NULL
A	NULL
Novel	NULL
Grb2	NULL
Family	NULL
Member	NULL
,	NULL
Is	NULL
Involved	NULL
in	NULL
T	NULL
Cell	NULL
Signaling	NULL
through	NULL
Interaction	NULL
with	NULL
SLP-76	NULL
and	NULL
LAT	NULL
By	NULL
Hiroshi	NULL
Asada	NULL
,	NULL
**	NULL
Naoto	NULL
Ishii	NULL
,	NULL
*	NULL
Yoshiteru	NULL
Sasaki	NULL
,	NULL
*	NULL
Kazuhiro	NULL
Endo	NULL
,	NULL
*	NULL
Hirotake	NULL
Kasai	NULL
,	NULL
*	NULL
Nobuyuki	NULL
Tanaka	NULL
,	NULL
*	NULL
Toshikazu	NULL
Takeshita	NULL
,	NULL
*	NULL
Shigeru	NULL
Tsuchiya	NULL
,	NULL
?	NULL

Tasuke	NULL
Konno	NULL
,	NULL
$	NULL
and	NULL
Kazuo	NULL
Sugamura®*	NULL
!	NULL

From	NULL
the	NULL
*Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
Tohoku	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Sendai	NULL
980-8575	NULL
,	NULL
Japan	NULL
;	NULL
the	NULL
*Department	NULL
of	NULL
Pediatric	NULL
O	NULL
nelogy	NULL
,	NULL
Institute	NULL
of	NULL
Development	NULL
,	NULL
A	NULL
ging	NULL
and	NULL
C	NULL
ancer	NULL
;	NULL
Tohoku	NULL
University	NULL
,	NULL
Sendi	NULL
980-8575	NULL
,	NULL
Japan	NULL
;	NULL
the	NULL
$	NULL
Research	NULL
Institute	NULL
Miyagi	NULL
Cancer	NULL
Center	NULL
N	NULL
atori	NULL
981-1293	NULL
,	NULL
Japan	NULL
;	NULL
and	NULL
Core	NULL
Research	NULL
for	NULL
Evolutional	NULL
Saence	NULL
and	NULL
Technology	NULL
(	NULL
CREST	NULL
)	NULL
,	NULL
Japan	NULL
Sdence	NULL
and	NULL
Technology	NULL
Corporation	NULL
,	NULL
Tokyo	NULL
101-0062	NULL
,	NULL
Japan	NULL
Summary	NULL
We	NULL
molecularly	NULL
cloned	NULL
a	NULL
new	NULL
Grb2	NULL
family	NULL
member	NULL
,	NULL
named	NULL
Grf40	NULL
,	NULL
containing	NULL
the	NULL
common	NULL
SH3-SH2-SH3	NULL
motif	NULL
.	NULL

Expression	NULL
of	NULL
Grf40	NULL
is	NULL
predominant	NULL
in	NULL
hematopoietic	NULL
cells	NULL
,	NULL
particularly	NULL
T	NULL
cells	NULL
Grf40	NULL
binds	NULL
to	NULL
the	NULL
SH2	NULL
domain-containing	NULL
leukocyte	NULL
protein	NULL
of	NULL
76	NULL
kD	NULL
(	NULL
SLP-76	NULL
)	NULL
via	NULL
its	NULL
SH3	NULL
domain	NULL
more	NULL
tightly	NULL
than	NULL
Grb2	NULL
.	NULL

Incidentally	NULL
,	NULL
Grf40	NULL
binds	NULL
to	NULL
linker	NULL
for	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
LAT	NULL
)	NULL
possibly	NULL
via	NULL
its	NULL
SH2	NULL
domain	NULL
.	NULL

O	NULL
verexpression	NULL
of	NULL
wild-type	NULL
Grf40	NULL
in	NULL
Jurkat	NULL
cells	NULL
induced	NULL
a	NULL
significant	NULL
increase	NULL
of	NULL
SLP-76-dependent	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-2	NULL
promoter	NULL
and	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cell	NULL
(	NULL
NF-AT	NULL
)	NULL
activation	NULL
upon	NULL
T	NULL
cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
stimulation	NULL
,	NULL
whereas	NULL
the	NULL
COOH-terminal	NULL
SH3-deleted	NULL
Grf40	NULL
mutant	NULL
lacked	NULL
any	NULL
recognizable	NULL
increase	NULL
in	NULL
IL-2	NULL
promoter	NULL
activity	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
SH2-deleted	NULL
Grf40	NULL
mutant	NULL
led	NULL
to	NULL
a	NULL
marked	NULL
inhibition	NULL
of	NULL
these	NULL
regulatory	NULL
activities	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
which	NULL
is	NULL
apparently	NULL
stronger	NULL
than	NULL
that	NULL
of	NULL
the	NULL
SH2-deleted	NULL
Grb2	NULL
mu-tant	NULL
.	NULL

Our	NULL
data	NULL
suggest	NULL
that	NULL
Grf4O0	NULL
is	NULL
an	NULL
adaptor	NULL
molecule	NULL
involved	NULL
in	NULL
TCR	NULL
-mediated	NULL
signaling	NULL
through	NULL
a	NULL
more	NULL
efficient	NULL
interaction	NULL
than	NULL
Grb2	NULL
with	NULL
SLP-76	NULL
and	NULL
LAT	NULL
.	NULL

Key	NULL
words	NULL
:	NULL
-	NULL
Grb2	NULL
family	NULL
«	NULL
SLP-76	NULL
«	NULL
T	NULL
cell	NULL
receptor	NULL
signaling	NULL
»	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
Stimulation	NULL
of	NULL
the	NULL
TCR	NULL
initiates	NULL
activation	NULL
of	NULL
cytoplasmic	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
(	NULL
PTKs	NULL
)	NULL
'	NULL
that	NULL
trigger	NULL
downstream	NULL
signaling	NULL
pathways	NULL
including	NULL
calcium-	NULL
and	NULL
Ras	NULL
dependent	NULL
events	NULL
,	NULL
which	NULL
ultimately	NULL
converge	NULL
upon	NULL
the	NULL
nucleus	NULL
to	NULL
stimulate	NULL
the	NULL
transcription	NULL
of	NULL
genes	NULL
required	NULL
for	NULL
proliferation	NULL
and	NULL
effector	NULL
functions	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
1-4	NULL
)	NULL
.	NULL

Phos	NULL
pholipase	NULL
Cy1	NULL
,	NULL
recruited	NULL
to	NULL
the	NULL
plasma	NULL
membrane	NULL
after	NULL
PTK	NULL
activation	NULL
,	NULL
is	NULL
thought	NULL
to	NULL
introduce	NULL
the	NULL
calcium-dependent	NULL
pathway	NULL
into	NULL
the	NULL
TCR	NULL
-mediated	NULL
signaling	NULL
events	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
pathway	NULL
for	NULL
Ras	NULL
activation	NULL
after	NULL
PTK	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
still	NULL
controversial	NULL
.	NULL

Grb2	NULL
,	NULL
an	NULL
adaptor	NULL
protein	NULL
containing	NULL
an	NULL
SH3-SH2-SH3	NULL
motif	NULL
,	NULL
forms	NULL
a	NULL
complex	NULL
with	NULL
Sos	NULL
,	NULL
a	NULL
guanine	NULL
nucleotide	NULL
exchange	NULL
factor	NULL
,	NULL
via	NULL
its	NULL
NH	NULL
-terminal	NULL
SH3	NULL
domain	NULL
after	NULL
TCR	NULL
ligation	NULL
(	NULL
7-9	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
the	NULL
Grb2-Sos	NULL
complex	NULL
is	NULL
thought	NULL
to	NULL
contribute	NULL
to	NULL
Ras	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
although	NULL
there	NULL
has	NULL
been	NULL
no	NULL
empirical	NULL
evidence	NULL
for	NULL
this	NULL
notion	NULL
.	NULL

The	NULL
COOH-terminal	NULL
SH3	NULL
domain	NULL
of	NULL
Grb2	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
SH2	NULL
domain-containing	NULL
leukocyte	NULL
'	NULL
A	NULL
bbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
LAT	NULL
,	NULL
linker	NULL
for	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
;	NULL
NF-AT	NULL
,	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
PTK	NULL
,	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
;	NULL
SLP-76	NULL
,	NULL
SH2	NULL
domain-containing	NULL
leukocyte	NULL
protein	NULL
of	NULL
76	NULL
kD	NULL
;	NULL
STAM	NULL
,	NULL
signal	NULL
transducing	NULL
adaptor	NULL
molecule	NULL
.	NULL

1383	NULL
protein	NULL
of	NULL
76	NULL
kD	NULL
(	NULL
SLP-76	NULL
)	NULL
,	NULL
a	NULL
hematopoietic	NULL
cell-specific	NULL
adaptor	NULL
protein	NULL
,	NULL
which	NULL
is	NULL
tyrosine	NULL
phosphorylated	NULL
rapidly	NULL
after	NULL
TCR	NULL
stimulation	NULL
(	NULL
10-12	NULL
)	NULL
.	NULL

Mice	NULL
targeted	NULL
for	NULL
SLP-76	NULL
gene	NULL
engendered	NULL
defects	NULL
of	NULL
double-positive	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
thymus	NULL
and	NULL
of	NULL
peripheral	NULL
T	NULL
cells	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
impaired	NULL
pre-TCR	NULL
signaling	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
Jurkat	NULL
subline	NULL
J14	NULL
cells	NULL
lacking	NULL
expression	NULL
of	NULL
SLP-76	NULL
exhibited	NULL
defects	NULL
of	NULL
both	NULL
the	NULL
calcium-	NULL
and	NULL
dependent	NULL
pathways	NULL
in	NULL
TCR-mediated	NULL
signaling	NULL
.	NULL

The	NULL
defect	NULL
of	NULL
the	NULL
calcium-dependent	NULL
pathway	NULL
in	NULL
this	NULL
system	NULL
is	NULL
ascribed	NULL
to	NULL
the	NULL
fact	NULL
that	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
phospholipase	NULL
Cy1	NULL
are	NULL
significantly	NULL
suppressed	NULL
in	NULL
J14	NULL
cells	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
precise	NULL
function	NULL
of	NULL
SLP-76	NULL
in	NULL
R	NULL
as	NULL
activation	NULL
is	NULL
still	NULL
obscure	NULL
,	NULL
it	NULL
is	NULL
of	NULL
interest	NULL
that	NULL
deletion	NULL
of	NULL
the	NULL
Grb2-	NULL
binding	NULL
site	NULL
of	NULL
SLP-76	NULL
eliminates	NULL
the	NULL
ability	NULL
of	NULL
SLP-76	NULL
to	NULL
increase	NULL
IL-2	NULL
promoter	NULL
activity	NULL
upon	NULL
stimulation	NULL
with	NULL
the	NULL
TCR	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
.	NULL

In	NULL
addi-tion	NULL
,	NULL
SLP-76	NULL
also	NULL
binds	NULL
to	NULL
Vav	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
guanine	NULL
nucleotide	NULL
exchange	NULL
factor	NULL
family	NULL
,	NULL
and	NULL
cotransfection	NULL
with	NULL
SLP-76	NULL
and	NULL
Vav	NULL
into	NULL
Jurkat	NULL
cells	NULL
induced	NULL
a	NULL
synergistic	NULL
increase	NULL
of	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cell	NULL
(	NULL
NF-AT	NULL
)	NULL
activation	NULL
upon	NULL
TCR	NULL
stimulation	NULL
(	NULL
17	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
that	NULL
SLP-76	NULL
is	NULL
an	NULL
indispensable	NULL
mediator	NULL
of	NULL
TCR	NULL
signaling	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
Grb2	NULL
has	NULL
been	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

©	NULL
The	NULL
R	NULL
ockefeller	NULL
University	NULL
Press	NULL
«	NULL
0022-1007/99/	NULL
05/	NULL
1383/08	NULL
$	NULL
2.00	NULL
Volume	NULL
189	NULL
,	NULL
Number	NULL
9	NULL
,	NULL
May	NULL
3	NULL
,	NULL
1999	NULL
1383-1390	NULL
http	NULL
:	NULL
//	NULL
www.jem.org	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
linker	NULL
for	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
LAT	NULL
)	NULL
,	NULL
a	NULL
ZAP-70	NULL
tyrosine	NULL
kinase	NULL
substrate	NULL
,	NULL
upon	NULL
TCR	NULL
stimulation	NULL
,	NULL
and	NULL
the	NULL
LAT	NULL
mutant	NULL
,	NULL
lacking	NULL
an	NULL
interaction	NULL
site	NULL
for	NULL
the	NULL
SH2	NULL
domain	NULL
,	NULL
has	NULL
a	NULL
dominant-negative	NULL
effect	NULL
on	NULL
TCR	NULL
-stim-ulated	NULL
signaling	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Hence	NULL
Grb2	NULL
,	NULL
an	NULL
adaptor	NULL
protein	NULL
,	NULL
has	NULL
been	NULL
considered	NULL
to	NULL
be	NULL
implicated	NULL
in	NULL
TCR	NULL
-mediated	NULL
signaling	NULL
.	NULL

We	NULL
here	NULL
provide	NULL
evidence	NULL
that	NULL
a	NULL
new	NULL
Grb2	NULL
family	NULL
member	NULL
,	NULL
named	NULL
Grf40	NULL
,	NULL
is	NULL
involved	NULL
in	NULL
TCR	NULL
-mediated	NULL
signaling	NULL
through	NULL
its	NULL
more	NULL
efficient	NULL
interaction	NULL
than	NULL
Grb2	NULL
with	NULL
SLP-76	NULL
and	NULL
LAT	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cloning	NULL
of	NULL
the	NULL
DNA	NULL
.	NULL

-	NULL
Grf40	NULL
cDNA	NULL
fragments	NULL
were	NULL
isolated	NULL
by	NULL
a	NULL
yeast	NULL
two-hybrid	NULL
screen	NULL
of	NULL
a	NULL
human	NULL
PHA-PBL	NULL
cDNA	NULL
library	NULL
(	NULL
Clontech	NULL
)	NULL
.	NULL

The	NULL
bait	NULL
plasmid	NULL
was	NULL
constructed	NULL
by	NULL
insertion	NULL
of	NULL
a	NULL
cDNA	NULL
fragment	NULL
encoding	NULL
the	NULL
full-length	NULL
human	NULL
AMSH	NULL
protein	NULL
(	NULL
our	NULL
unpublished	NULL
protocol	NULL
)	NULL
in	NULL
pAS2-1	NULL
(	NULL
Clontech	NULL
)	NULL
.	NULL

The	NULL
bait	NULL
plasmid	NULL
was	NULL
transformed	NULL
into	NULL
the	NULL
yeast	NULL
strain	NULL
C€CG1945	NULL
(	NULL
Clon-tech	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
transformation	NULL
with	NULL
the	NULL
human	NULL
PHA-PBL	NULL
cDN	NULL
A	NULL
library	NULL
.	NULL

The	NULL
transformed	NULL
strains	NULL
were	NULL
selected	NULL
on	NULL
dropout	NULL
plates	NULL
(	NULL
Trp~	NULL
,	NULL
Leu~	NULL
,	NULL
His~	NULL
)	NULL
with	NULL
5	NULL
mM	NULL
3-aminotriazole	NULL
.	NULL

Positive	NULL
colonies	NULL
were	NULL
subsequently	NULL
tested	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
lacZ	NULL
.	NULL

One	NULL
clone	NULL
was	NULL
determined	NULL
to	NULL
contain	NULL
a	NULL
homologous	NULL
sequence	NULL
to	NULL
Grb2	NULL
(	NULL
7	NULL
)	NULL
.	NULL

To	NULL
obtain	NULL
the	NULL
full-length	NULL
cDNA	NULL
,	NULL
the	NULL
800-bp	NULL
fragment	NULL
of	NULL
the	NULL
above	NULL
clone	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
for	NULL
screening	NULL
a	NULL
Agtll	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
-primed	NULL
cDN	NULL
A	NULL
library	NULL
of	NULL
PHA-PBL	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
10	NULL
clones	NULL
were	NULL
identical	NULL
,	NULL
and	NULL
two	NULL
of	NULL
them	NULL
contained	NULL
an	NULL
open	NULL
reading	NULL
frame	NULL
coding	NULL
for	NULL
330	NULL
amino	NULL
acids	NULL
.	NULL

This	NULL
sequence	NULL
contains	NULL
an	NULL
in-frame	NULL
stop	NULL
codon	NULL
at	NULL
114	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
first	NULL
methionine	NULL
codon	NULL
,	NULL
and	NULL
the	NULL
sequence	NULL
around	NULL
the	NULL
first	NULL
methionine	NULL
(	NULL
nucleotides	NULL
193-195	NULL
)	NULL
matches	NULL
the	NULL
favorable	NULL
Kozak	NULL
consensus	NULL
se-quence	NULL
.	NULL

A	NULL
full-length	NULL
cDNA	NULL
encoding	NULL
Grf40	NULL
was	NULL
thus	NULL
isolated	NULL
.	NULL

Plasmid	NULL
Construdion	NULL
.	NULL

_	NULL
GtfAQ	NULL
cDNA	NULL
was	NULL
generated	NULL
by	NULL
PCR	NULL
using	NULL
the	NULL
above	NULL
full-length	NULL
cDNA	NULL
clone	NULL
as	NULL
a	NULL
template	NULL
and	NULL
subcloned	NULL
into	NULL
Myc-Tag-peDNA3.1	NULL
(	NULL
+	NULL
)	NULL
to	NULL
generate	NULL
the	NULL
plasmid	NULL
sequence	NULL
(	NULL
EQ	NULL
KLISEEDL	NULL
)	NULL
.	NULL

pMycGrfO-dSH3N	NULL
,	NULL
pMycGrfQ-dSH2	NULL
,	NULL
pMycGrf40-dSH3C	NULL
,	NULL
and	NULL
pMycGrf0-dSH3NC	NULL
are	NULL
Myc-tagged	NULL
Grf40	NULL
mutants	NULL
deleted	NULL
of	NULL
the	NULL
SH3	NULL
domain	NULL
of	NULL
the	NULL
NH	NULL
,	NULL
terminus	NULL
(	NULL
amino	NULL
acid	NULL
position	NULL
Met'-Pro	NULL
%	NULL
)	NULL
,	NULL
deleted	NULL
of	NULL
the	NULL
SH2	NULL
domain	NULL
(	NULL
amino	NULL
acid	NULL
position	NULL
Lys*-Thr'*	NULL
)	NULL
,	NULL
of	NULL
the	NULL
SH3	NULL
domain	NULL
of	NULL
the	NULL
COOH	NULL
terminus	NULL
(	NULL
amino	NULL
acid	NULL
position	NULL
Ala	NULL
``	NULL
``	NULL
``	NULL
-Arg	NULL
``	NULL
``	NULL
``	NULL
)	NULL
,	NULL
and	NULL
of	NULL
the	NULL
SH3	NULL
domains	NULL
of	NULL
the	NULL
NH	NULL
,	NULL
,	NULL
and	NULL
COOH	NULL
termini	NULL
(	NULL
amino	NULL
acid	NULL
positions	NULL
Met	NULL
!	NULL

-Pro	NULL
%	NULL
®	NULL
and	NULL
Ala	NULL
``	NULL
``	NULL
``	NULL
-Arg	NULL
``	NULL
``	NULL
``	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

pMycGrb2	NULL
and	NULL
pMycGrb2-dSH2	NULL
are	NULL
expression	NULL
plasmids	NULL
for	NULL
the	NULL
Myc-tagged	NULL
wild-type	NULL
Grb2	NULL
and	NULL
Grb2	NULL
mutant	NULL
deleted	NULL
of	NULL
the	NULL
SH2	NULL
domain	NULL
(	NULL
amino	NULL
acid	NULL
position	NULL
Trp-Glu'*	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

SLP-76	NULL
cDNA	NULL
was	NULL
generated	NULL
by	NULL
PCR	NULL
and	NULL
subcloned	NULL
into	NULL
pFLAG-CMV-2	NULL
(	NULL
East-man	NULL
Kodak	NULL
Co.	NULL
)	NULL
to	NULL
generate	NULL
the	NULL
plasmid	NULL
pFlagSLP	NULL
,	NULL
possessing	NULL
an	NULL
NH-terminal	NULL
Flag	NULL
epitope	NULL
tag	NULL
(	NULL
DYKDDDDK	NULL
)	NULL
.	NULL

pFlagSLP-157-533	NULL
,	NULL
pFlagSLP-217-533	NULL
,	NULL
pFlagSLP-241-533	NULL
,	NULL
and	NULL
pFlagSLP-281-533	NULL
are	NULL
expression	NULL
plasmids	NULL
for	NULL
Flag-tagged	NULL
SLP-76	NULL
mutants	NULL
deleted	NULL
of	NULL
amino	NULL
acid	NULL
positions	NULL
Met'-Lew	NULL
'	NULL
``	NULL
``	NULL
,	NULL
Met'-His	NULL
?	NULL

``	NULL
``	NULL
,	NULL
Met'-Lys	NULL
``	NULL
,	NULL
and	NULL
Met'-Pro	NULL
``	NULL
*	NULL
``	NULL
,	NULL
respectively	NULL
.	NULL

pCX-SLP76	NULL
is	NULL
an	NULL
expression	NULL
plasmid	NULL
for	NULL
the	NULL
wild-type	NULL
SLP-76	NULL
cloned	NULL
into	NULL
the	NULL
pCXN2	NULL
vector	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Luciferase	NULL
reporter	NULL
constructs	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
pNFATLuc	NULL
was	NULL
constructed	NULL
by	NULL
insertion	NULL
of	NULL
three	NULL
tandem	NULL
copies	NULL
of	NULL
the	NULL
NF-AT	NULL
binding	NULL
region	NULL
(	NULL
-286	NULL
to	NULL
-249	NULL
of	NULL
human	NULL
IL-2	NULL
)	NULL
linked	NULL
to	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
(	NULL
-64	NULL
to	NULL
+47	NULL
)	NULL
into	NULL
the	NULL
pGL3-basic	NULL
vector	NULL
(	NULL
Promega	NULL
)	NULL
(	NULL
20	NULL
)	NULL
;	NULL
pIL2Luc	NULL
was	NULL
constructed	NULL
by	NULL
insertion	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
(	NULL
-541	NULL
to	NULL
+57	NULL
)	NULL
into	NULL
the	NULL
pGL3-basic	NULL
vector	NULL
(	NULL
21	NULL
)	NULL
.	NULL

pENL	NULL
is	NULL
a	NULL
B-galactosidase	NULL
expression	NULL
plasmid	NULL
(	NULL
22	NULL
)	NULL
.	NULL

All	NULL
con	NULL
1384	NULL
structs	NULL
were	NULL
sequenced	NULL
for	NULL
verification	NULL
with	NULL
a	NULL
DNA	NULL
sequencer	NULL
(	NULL
model	NULL
377	NULL
;	NULL
Applied	NULL
Biosystems	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

Cell	NULL
Culture	NULL
.	NULL

-	NULL
Cell	NULL
lines	NULL
used	NULL
were	NULL
human	NULL
T	NULL
cell	NULL
lines	NULL
,	NULL
Jurkat	NULL
and	NULL
MOLT-4	NULL
;	NULL
human	NULL
B	NULL
cell	NULL
lines	NULL
,	NULL
Daudi	NULL
,	NULL
Raji	NULL
,	NULL
and	NULL
Ramos	NULL
;	NULL
a	NULL
human	NULL
monocytic	NULL
cell	NULL
line	NULL
,	NULL
THP-1	NULL
;	NULL
a	NULL
human	NULL
eosinophilic	NULL
cell	NULL
line	NULL
,	NULL
Eol-3	NULL
;	NULL
a	NULL
human	NULL
GM-CSF-responsive	NULL
cell	NULL
line	NULL
,	NULL
TF-1	NULL
;	NULL
a	NULL
human	NULL
lung	NULL
fibroblastic	NULL
cell	NULL
line	NULL
,	NULL
WI-26	NULL
;	NULL
a	NULL
human	NULL
epithelial	NULL
cell	NULL
line	NULL
,	NULL
HeLa	NULL
;	NULL
and	NULL
an	NULL
SV40-transformed	NULL
monkey	NULL
kidney	NULL
cell	NULL
line	NULL
,	NULL
CO	NULL
S7	NULL
.	NULL

TF-1	NULL
was	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
and	NULL
recombinant	NULL
GM-CSF	NULL
.	NULL

WI-26	NULL
and	NULL
COS7	NULL
were	NULL
maintained	NULL
in	NULL
DME	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
FCS	NULL
.	NULL

Other	NULL
cell	NULL
lines	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
.	NULL

Abs	NULL
.	NULL

The	NULL
following	NULL
Abs	NULL
were	NULL
used	NULL
in	NULL
this	NULL
study	NULL
:	NULL
anti-CD3e	NULL
mAb	NULL
OKT3	NULL
(	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
)	NULL
;	NULL
antiphosphotyrosine	NULL
mAb	NULL
4G10	NULL
,	NULL
anti-Myc	NULL
polyclonal	NULL
Ab	NULL
and	NULL
anti-LAT	NULL
Ab	NULL
(	NULL
Upstate	NULL
Biotechnology	NULL
)	NULL
;	NULL
antiphosphotyrosine	NULL
mAb	NULL
PY-20	NULL
(	NULL
ICN	NULL
Biomedicals	NULL
)	NULL
;	NULL
anti-Myc	NULL
mAb	NULL
(	NULL
9E10	NULL
)	NULL
and	NULL
anti-Grb2	NULL
Ab	NULL
(	NULL
sc-255	NULL
)	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
;	NULL
anti-Flag	NULL
mAb	NULL
(	NULL
M2	NULL
;	NULL
Eastman	NULL
Kodak	NULL
Co.	NULL
)	NULL
.	NULL

Anti-Grf40	NULL
rabbit	NULL
antiserum	NULL
was	NULL
prepared	NULL
by	NULL
immunization	NULL
with	NULL
a	NULL
peptide	NULL
(	NULL
Val	NULL
'	NULL
``	NULL
+-Pro	NULL
'	NULL
)	NULL
of	NULL
human	NULL
Grf40	NULL
.	NULL

Anti-SLP-76	NULL
rabbit	NULL
antiserum	NULL
was	NULL
prepared	NULL
by	NULL
immunization	NULL
with	NULL
a	NULL
peptide	NULL
of	NULL
human	NULL
SLP-76	NULL
.	NULL

Anti-B19	NULL
human	NULL
parvovirus	NULL
mAb	NULL
(	NULL
Parl	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
mAb	NULL
.	NULL

Immunopredpitation	NULL
and	NULL
Immunoblotting	NULL
.	NULL

_	NULL
Immunoprecipitation	NULL
and	NULL
immunoblotting	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
23	NULL
)	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
with	NULL
a	NULL
cell	NULL
extraction	NULL
buffer	NULL
(	NULL
1	NULL
%	NULL
NP-40	NULL
,	NULL
20	NULL
mM	NULL
Tris	NULL
HCI	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
Na	NULL
;	NULL
VO	NULL
,	NULL
,	NULL
2	NULL
mM	NULL
PMSF	NULL
,	NULL
and	NULL
20	NULL
g/ml	NULL
aprotinin	NULL
)	NULL
,	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
the	NULL
indicated	NULL
Abs	NULL
or	NULL
antisera	NULL
.	NULL

The	NULL
immunoprecipitates	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
then	NULL
transferred	NULL
to	NULL
polyvinylidene	NULL
difluoride	NULL
filters	NULL
(	NULL
Millipore	NULL
)	NULL
.	NULL

After	NULL
incubation	NULL
in	NULL
PBS	NULL
containing	NULL
2	NULL
%	NULL
BSA	NULL
and	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
,	NULL
the	NULL
filters	NULL
were	NULL
probed	NULL
with	NULL
the	NULL
indicated	NULL
Abs	NULL
and	NULL
visualized	NULL
using	NULL
the	NULL
ECL	NULL
detection	NULL
system	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
.	NULL

Northem	NULL
Blotting	NULL
.	NULL

-	NULL
Notthern	NULL
blot	NULL
analyses	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
24	NULL
)	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
a	NULL
Multiple	NULL
Tissue	NULL
Northern	NULL
blot	NULL
containing	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RN	NULL
A	NULL
preparations	NULL
derived	NULL
from	NULL
various	NULL
human	NULL
tissues	NULL
was	NULL
purchased	NULL
(	NULL
Clontech	NULL
)	NULL
.	NULL

They	NULL
were	NULL
probed	NULL
with	NULL
radiolabeled	NULL
cDN	NULL
A	NULL
fragments	NULL
of	NULL
Grf40	NULL
and	NULL
B-actin	NULL
.	NULL

Signals	NULL
were	NULL
analyzed	NULL
with	NULL
a	NULL
Bio-Image	NULL
Analyzer	NULL
,	NULL
BAS	NULL
1500	NULL
(	NULL
Fuji	NULL
Film	NULL
and	NULL
Photo	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

Transient	NULL
Transfections	NULL
and	NULL
Ludferase	NULL
Assay	NULL
.	NULL

_	NULL
COST	NULL
cells	NULL
were	NULL
electroporated	NULL
with	NULL
the	NULL
indicated	NULL
plasmids	NULL
in	NULL
OPTI-MEM	NULL
I	NULL
(	NULL
GIBCO	NULL
BRL	NULL
)	NULL
at	NULL
a	NULL
density	NULL
of	NULL
6	NULL
X	NULL
10°	NULL
celly	NULL
700	NULL
p/	NULL
cuvette	NULL
with	NULL
a	NULL
gene	NULL
pulser	NULL
(	NULL
Bio-R	NULL
ad	NULL
Laboratories	NULL
)	NULL
set	NULL
at	NULL
1,000	NULL
V	NULL
and	NULL
200	NULL
F	NULL
,	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
a	NULL
Western	NULL
blot	NULL
assay	NULL
48	NULL
h	NULL
after	NULL
the	NULL
trans-fection	NULL
.	NULL

For	NULL
luciferase	NULL
assays	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
electroporated	NULL
with	NULL
2.5	NULL
jug	NULL
of	NULL
pENL	NULL
and	NULL
the	NULL
indicated	NULL
dose	NULL
of	NULL
pIL2Luc	NULL
or	NULL
pNFATLuc	NULL
,	NULL
along	NULL
with	NULL
expression	NULL
plasmids	NULL
for	NULL
SLP-76	NULL
,	NULL
and	NULL
Grf40	NULL
or	NULL
Grb2	NULL
in	NULL
OPTI-MEM	NULL
I	NULL
at	NULL
a	NULL
density	NULL
of	NULL
5	NULL
X	NULL
10°	NULL
celly	NULL
400	NULL
pul	NULL
at	NULL
200	NULL
V	NULL
and	NULL
950	NULL
wF	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
cultured	NULL
at	NULL
37°C	NULL
for	NULL
24	NULL
h	NULL
,	NULL
and	NULL
then	NULL
stimulated	NULL
for	NULL
8	NULL
h	NULL
with	NULL
10	NULL
g/	NULL
ml	NULL
OKT	NULL
3	NULL
plus	NULL
50	NULL
ng/	NULL
ml	NULL
PMA	NULL
or	NULL
with	NULL
10	NULL
pg/ml	NULL
OKT3	NULL
alone	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
lysed	NULL
in	NULL
300	NULL
pl	NULL
of	NULL
PicaGene	NULL
ReporterLysis	NULL
Buffer	NULL
(	NULL
Toyo	NULL
Ink	NULL
)	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
and	NULL
-galactosidase	NULL
activities	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Results	NULL
and	NULL
Discussion	NULL
We	NULL
previously	NULL
reported	NULL
a	NULL
signal	NULL
transducing	NULL
adaptor	NULL
molecule	NULL
,	NULL
STAM	NULL
,	NULL
which	NULL
is	NULL
associated	NULL
with	NULL
Janus	NULL
kinase	NULL
(	NULL
Jak	NULL
)	NULL
2	NULL
and	NULL
Jak3	NULL
and	NULL
is	NULL
involved	NULL
in	NULL
signal	NULL
transduction	NULL
medi-	NULL
Grf40	NULL
Involved	NULL
in	NULL
T	NULL
Cell	NULL
Signaling	NULL
ated	NULL
by	NULL
IL-2	NULL
and	NULL
GM-CSF	NULL
(	NULL
26	NULL
)	NULL
.	NULL

We	NULL
have	NULL
also	NULL
recently	NULL
cloned	NULL
a	NULL
cDNA	NULL
clone	NULL
encoding	NULL
a	NULL
novel	NULL
molecule	NULL
,	NULL
named	NULL
AMSH	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
STAM	NULL
(	NULL
our	NULL
unpublished	NULL
results	NULL
)	NULL
.	NULL

To	NULL
address	NULL
the	NULL
functional	NULL
significance	NULL
of	NULL
AMSH	NULL
,	NULL
we	NULL
attempted	NULL
to	NULL
identify	NULL
molecules	NULL
associated	NULL
with	NULL
AMSH	NULL
using	NULL
the	NULL
yeast	NULL
two-hybrid	NULL
assay	NULL
system	NULL
.	NULL

One	NULL
full-length	NULL
cDNA	NULL
clone	NULL
was	NULL
isolated	NULL
from	NULL
a	NULL
human	NULL
PHA-PBL	NULL
cDN	NULL
A	NULL
library	NULL
.	NULL

The	NULL
cDNA	NULL
clone	NULL
encodes	NULL
a	NULL
molecule	NULL
homologous	NULL
to	NULL
Grb2	NULL
,	NULL
named	NULL
Grf40	NULL
(	NULL
for	NULL
Grb2	NULL
family	NULL
member	NULL
of	NULL
40	NULL
kD	NULL
)	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
Grf40	NULL
gene	NULL
has	NULL
been	NULL
deposited	NULL
with	NULL
GenBank	NULL
,	NULL
and	NULL
is	NULL
available	NULL
from	NULL
EMBL/	NULL
Gen-Bank/	NULL
DDBJ	NULL
under	NULL
accession	NULL
no	NULL
.	NULL

AFO42380	NULL
.	NULL

The	NULL
deduced	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
Grf40	NULL
consists	NULL
of	NULL
330	NULL
amino	NULL
acid	NULL
residues	NULL
.	NULL

The	NULL
schematic	NULL
structure	NULL
of	NULL
Grf40	NULL
was	NULL
compared	NULL
with	NULL
Grb2	NULL
(	NULL
7	NULL
)	NULL
and	NULL
Grap	NULL
,	NULL
another	NULL
Grb2	NULL
family	NULL
member	NULL
(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
.	NULL

The	NULL
NH	NULL
,	NULL
-	NULL
and	NULL
COOH-terminal	NULL
SH3	NULL
domains	NULL
and	NULL
an	NULL
intermediate	NULL
SH2	NULL
domain	NULL
of	NULL
Grf40	NULL
are	NULL
highly	NULL
homologous	NULL
to	NULL
those	NULL
of	NULL
Grb2	NULL
and	NULL
Grap	NULL
,	NULL
while	NULL
a	NULL
unique	NULL
insert	NULL
region	NULL
(	NULL
amino	NULL
acid	NULL
position	NULL
Arg	NULL
'	NULL
``	NULL
``	NULL
-Arg	NULL
``	NULL
``	NULL
``	NULL
)	NULL
containing	NULL
proline/	NULL
glutamine-rich	NULL
sequences	NULL
was	NULL
seen	NULL
in	NULL
Grf40	NULL
but	NULL
not	NULL
Grb2	NULL
and	NULL
Grap	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
Grf4O0	NULL
is	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
Grb2	NULL
family	NULL
.	NULL

Various	NULL
human	NULL
cell	NULL
lines	NULL
were	NULL
examined	NULL
for	NULL
expression	NULL
of	NULL
Grf40	NULL
by	NULL
immunoblotting	NULL
with	NULL
anti-Grf40	NULL
Ab	NULL
.	NULL

Two	NULL
T	NULL
cell	NULL
lines	NULL
,	NULL
MOLT-4	NULL
and	NULL
Jurkat	NULL
,	NULL
were	NULL
strongly	NULL
positive	NULL
for	NULL
expression	NULL
of	NULL
the	NULL
40-kD	NULL
Grf4O0	NULL
,	NULL
and	NULL
two	NULL
B	NULL
cell	NULL
lines	NULL
,	NULL
Daudi	NULL
and	NULL
R	NULL
aji	NULL
,	NULL
were	NULL
weakly	NULL
positive	NULL
,	NULL
but	NULL
the	NULL
other	NULL
cell	NULL
lines	NULL
,	NULL
including	NULL
a	NULL
B	NULL
cell	NULL
line	NULL
(	NULL
R	NULL
amos	NULL
)	NULL
,	NULL
myeloid	NULL
cell	NULL
lines	NULL
(	NULL
THP-1	NULL
,	NULL
TF-1	NULL
,	NULL
and	NULL
Eol-3	NULL
)	NULL
,	NULL
and	NULL
the	NULL
nonhematopoietic	NULL
cell	NULL
lines	NULL
(	NULL
HeLa	NULL
and	NULL
WI-26	NULL
)	NULL
were	NULL
all	NULL
negative	NULL
for	NULL
this	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
Grf40	NULL
,	NULL
appreciable	NULL
expression	NULL
of	NULL
Grb2	NULL
was	NULL
seen	NULL
in	NULL
all	NULL
the	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
)	NULL
.	NULL

Northern	NULL
blot	NULL
A	NULL
5	NULL
53	NULL
60	NULL
158	NULL
163	NULL
210	NULL
217	NULL
Grb2	NULL
-	NULL
N	NULL
ESH32	NULL
SH2	NULL
ZSHliz	NULL
C	NULL
to	NULL
§1	NULL
%	NULL
1	NULL
:	NULL
57	NULL
%	NULL
f	NULL
~-i5	NULL
51	NULL
!	NULL

(	NULL
58	NULL
155	NULL
!	NULL

190	NULL
-	NULL
220	NULL
~~~	NULL
.	NULL

278	NULL
325	NULL
.	NULL

330	NULL
Sy	NULL
7	NULL
Grf40	NULL
N|	NULL
#	NULL
SH3	NULL
SH2	NULL
AP/Q	NULL
|	NULL
C	NULL
|	NULL
ou	NULL
$	NULL
f	NULL
A	NULL
``	NULL
1	NULL
49	NULL
%	NULL
11	NULL
57	NULL
%	NULL
1	NULL
.~	NULL
*	NULL
40	NULL
%	NULL
,	NULL
-~	NULL
*	NULL
's	NULL
__	NULL
53	NULL
!	NULL

!	NULL

60	NULL
158	NULL
!	NULL

1657	NULL
``	NULL
212	NULL
.	NULL

217	NULL
``	NULL
rp	NULL
7	NULL
Grap	NULL
-	NULL
N	NULL
SH2	NULL
C	NULL
%	NULL
#	NULL
©	NULL
aC	NULL
B	NULL
C	NULL
&	NULL
y	NULL
£	NULL
&	NULL
-o	NULL
oz	NULL
$	NULL
.-	NULL
£	NULL
3	NULL
,	NULL
-9.2-	NULL
,	NULL
é	NULL
'	NULL
x	NULL
‘	NULL
g	NULL
'	NULL
66	NULL
>	NULL
é	NULL
‘	NULL
:	NULL
F	NULL
o	NULL
€	NULL
%	NULL
=	NULL
1g	NULL
=	NULL
E	NULL
g.	NULL
``	NULL
1	NULL
?	NULL

2	NULL
g	NULL
\sz	NULL
'	NULL
6\	NULL
éQ	NULL
``	NULL
dQX	NULL
00V	NULL
95	NULL
‘	NULL
6	NULL
‘	NULL
Gag	NULL
&	NULL
xC	NULL
000°	NULL
5	NULL
5	NULL
8	NULL
8	NULL
$	NULL
$	NULL
F	NULL
&	NULL
§	NULL
2	NULL
&	NULL
-	NULL
Cou	NULL
sL	NULL
‘	NULL
«	NULL
tit	NULL
-	NULL
ca	NULL
-a	NULL
Grf40	NULL
IP	NULL
:	NULL
Cont	NULL
a	NULL
Grf40	NULL
*	NULL
C	NULL
IB	NULL
:	NULL
a	NULL
Grf4o	NULL
lng	NULL
-	NULL
3.5	NULL
kb	NULL
«	NULL
-~	NULL
RBR	NULL
UE	NULL
&	NULL
)	NULL
k	NULL
i-	NULL
a	NULL
#	NULL
-	NULL
<	NULL
1.5	NULL
kb	NULL
IP	NULL
:	NULL
1B	NULL
:	NULL
a	NULL
Grb2	NULL
Seeseees	NULL
|	NULL
[	NULL
e®	NULL
-	NULL
>	NULL
...	NULL

Figure	NULL
1	NULL
.	NULL

-	NULL
Schematic	NULL
structure	NULL
and	NULL
expression	NULL
of	NULL
Grf40	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
schematic	NULL
structure	NULL
of	NULL
Grf40	NULL
was	NULL
compared	NULL
with	NULL
Grb2	NULL
and	NULL
Grap	NULL
.	NULL

The	NULL
percentages	NULL
of	NULL
amino	NULL
acid	NULL
identity	NULL
of	NULL
the	NULL
SH3	NULL
and	NULL
SH2	NULL
domains	NULL
of	NULL
Grf40	NULL
with	NULL
Grb2	NULL
and	NULL
Grap	NULL
were	NULL
indicated	NULL
in	NULL
terms	NULL
of	NULL
their	NULL
SH3	NULL
and	NULL
SH2	NULL
domains	NULL
.	NULL

(	NULL
B	NULL
)	NULL
10	NULL
cells	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
human	NULL
cell	NULL
lines	NULL
were	NULL
immunoprecipitated	NULL
(	NULL
IP	NULL
)	NULL
and	NULL
immunoblotted	NULL
(	NULL
IB	NULL
)	NULL
with	NULL
anti-	NULL
Grf40	NULL
,	NULL
anti-Grb2	NULL
,	NULL
or	NULL
preimmune	NULL
(	NULL
control	NULL
[	NULL
Cont	NULL
]	NULL
)	NULL
serum	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Northern	NULL
blot	NULL
analyses	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
various	NULL
human	NULL
tissues	NULL
indicated	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
first	NULL
hybridized	NULL
with	NULL
the	NULL
Grf40	NULL
probe	NULL
,	NULL
then	NULL
rehy-bridized	NULL
with	NULL
B-actin	NULL
probe	NULL
.	NULL

1385	NULL
Asada	NULL
et	NULL
al	NULL
.	NULL

analyses	NULL
on	NULL
various	NULL
human	NULL
cell	NULL
lines	NULL
and	NULL
tissues	NULL
showed	NULL
two	NULL
Grf4O-specific	NULL
transcripts	NULL
at	NULL
3.5	NULL
and	NULL
1.5	NULL
kb	NULL
in	NULL
Jurkat	NULL
,	NULL
MOLT-4	NULL
,	NULL
three	NULL
myeloid	NULL
cell	NULL
lines	NULL
(	NULL
KU812	NULL
,	NULL
K562	NULL
,	NULL
and	NULL
M-TAT	NULL
)	NULL
and	NULL
PHA-PBL	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
and	NULL
in	NULL
human	NULL
immunotissues	NULL
such	NULL
as	NULL
thymus	NULL
,	NULL
spleen	NULL
,	NULL
small	NULL
intestine	NULL
,	NULL
and	NULL
PBL	NULL
,	NULL
whereas	NULL
marginal	NULL
levels	NULL
of	NULL
the	NULL
transcripts	NULL
were	NULL
detected	NULL
in	NULL
other	NULL
tissues	NULL
,	NULL
including	NULL
prostate	NULL
,	NULL
testis	NULL
,	NULL
ovary	NULL
,	NULL
colon	NULL
,	NULL
heart	NULL
,	NULL
brain	NULL
,	NULL
placenta	NULL
,	NULL
lung	NULL
,	NULL
liver	NULL
,	NULL
skeletal	NULL
muscle	NULL
,	NULL
kidney	NULL
,	NULL
and	NULL
pancreas	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
C	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
Grf4O0	NULL
,	NULL
unlike	NULL
Grb2	NULL
,	NULL
is	NULL
predominantly	NULL
expressed	NULL
in	NULL
immunotissues	NULL
and	NULL
hematopoietic	NULL
cells	NULL
,	NULL
particularly	NULL
T	NULL
cells	NULL
.	NULL

Since	NULL
Grb2	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
SLP-76	NULL
and	NULL
LAT	NULL
,	NULL
which	NULL
are	NULL
76-	NULL
and	NULL
36/	NULL
38-kD	NULL
tyrosine-	NULL
phosphorylated	NULL
proteins	NULL
essential	NULL
for	NULL
TCR-mediated	NULL
signaling	NULL
,	NULL
respectively	NULL
(	NULL
10	NULL
,	NULL
11	NULL
,	NULL
18	NULL
)	NULL
,	NULL
we	NULL
asked	NULL
ourselves	NULL
whether	NULL
or	NULL
not	NULL
Grf40	NULL
is	NULL
also	NULL
associated	NULL
with	NULL
SLP-76	NULL
and	NULL
LAT	NULL
.	NULL

We	NULL
detected	NULL
76-	NULL
and	NULL
36/	NULL
38-kD	NULL
tyrosine-phosphorylated	NULL
proteins	NULL
that	NULL
coimmunoprecipitated	NULL
with	NULL
Grf40	NULL
in	NULL
Jurkat	NULL
cells	NULL
after	NULL
stimulation	NULL
by	NULL
C	NULL
Stimulation	NULL
+	NULL
TCR	NULL
cross-linking	NULL
with	NULL
OKT3	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
)	NULL
.	NULL

We	NULL
then	NULL
confirmed	NULL
that	NULL
the	NULL
76-	NULL
and	NULL
36/	NULL
38-kD	NULL
tyrosine-phosphorylated	NULL
proteins	NULL
were	NULL
SLP-76	NULL
and	NULL
LAT	NULL
,	NULL
respectively	NULL
,	NULL
by	NULL
stimulating	NULL
Jurkat	NULL
cells	NULL
with	NULL
OKT3	NULL
.	NULL

Their	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-	NULL
Grf40	NULL
Ab	NULL
,	NULL
and	NULL
the	NULL
immunoprecipitates	NULL
were	NULL
then	NULL
immunoblotted	NULL
with	NULL
anti-LAT	NULL
,	NULL
anti-SLP-76	NULL
,	NULL
or	NULL
anti-	NULL
Grfi0	NULL
Ab	NULL
.	NULL

Grf40	NULL
precipitated	NULL
SLP-76	NULL
irrespective	NULL
of	NULL
TCR	NULL
stimulation	NULL
,	NULL
but	NULL
precipitated	NULL
LAT	NULL
only	NULL
after	NULL
TCR	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
the	NULL
association	NULL
of	NULL
Grf40	NULL
with	NULL
SLP-76	NULL
and	NULL
LAT	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
association	NULL
site	NULL
of	NULL
Grf40	NULL
for	NULL
SLP-76	NULL
,	NULL
we	NULL
carried	NULL
out	NULL
further	NULL
coimmunoprecipitation	NULL
assays	NULL
between	NULL
the	NULL
various	NULL
deletion	NULL
mutants	NULL
of	NULL
Grf40	NULL
and	NULL
SLP-76	NULL
.	NULL

COS7	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
Myc-tagged	NULL
wild-type	NULL
Grf4O	NULL
and	NULL
four	NULL
Grf4O	NULL
mutants	NULL
deleted	NULL
of	NULL
the	NULL
NH	NULL
,	NULL
-terminal	NULL
SH3	NULL
domain	NULL
(	NULL
Grf40-dSH3N	NULL
)	NULL
,	NULL
the	NULL
COOH-terminal	NULL
SH3	NULL
domain	NULL
(	NULL
Grf40-dSH3C	NULL
)	NULL
,	NULL
both	NULL
the	NULL
NH	NULL
,	NULL
-	NULL
and	NULL
COOH-terminal	NULL
SH3	NULL
domains	NULL
(	NULL
GrfO0-dSH3NC	NULL
)	NULL
,	NULL
or	NULL
the	NULL
SH2	NULL
domain	NULL
miogr	NULL
'	NULL
g	NULL
vector	NULL
sue-ze	NULL
€	NULL
g	NULL
J	NULL
a	NULL
o	NULL
n	NULL
$	NULL
§	NULL
$	NULL
$	NULL
8	NULL
a	NULL
g	NULL
§	NULL
6	NULL
6	NULL
3	NULL
S3	NULL
I	NULL
I	NULL
I	NULL
xr	NULL
o	NULL
&	NULL
o	NULL
&	NULL
E	NULL
E	NULL
t	NULL
Q	NULL
®	NULL
r-4	NULL
r	NULL
--	NULL
r	NULL
--	NULL
©	NULL
U	NULL
%	NULL
s	NULL
ke	NULL
1B	NULL
:	NULL
Py	NULL
t	NULL
h	NULL
m	NULL
wae	NULL
cam	NULL
cae	NULL
CP	NULL
«	NULL
am	NULL
»	NULL
-	NULL
wild	NULL
a	NULL
|	NULL
l	NULL
-	NULL
<	NULL
dSH3N	NULL
a	NULL
%	NULL
.	NULL

IP	NULL
:	NULL
control	NULL
a	NULL
SLP-76	NULL
'	NULL
B	NULL
:	NULL
«	NULL
Mys	NULL
Figure	NULL
2	NULL
.	NULL

Coimmunoprecipitation	NULL
of	NULL
IP	NULL
:	NULL
a	NULL
SLP-756	NULL
s	NULL
o	NULL
hm	NULL
e	NULL
he	NULL
k	NULL
SLP-76	NULL
and	NULL
LAT	NULL
with	NULL
Grf40	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

|	NULL
«	NULL
aim	NULL
ap	NULL
am	NULL
»	NULL
-	NULL
»	NULL
)	NULL
-a	NULL
SLP-76	NULL
-	NULL
'	NULL
MWB	NULL
|	NULL
is	NULL
:	NULL
«	NULL
sLp.75	NULL
*=	NULL
®	NULL
»	NULL
ee	NULL
Jurkat	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
(	NULL
+	NULL
)	NULL
or	NULL
without	NULL
(	NULL
-	NULL
)	NULL
OKT3	NULL
for	NULL
3	NULL
min	NULL
,	NULL
and	NULL
their	NULL
ly	NULL
--	NULL
~	NULL
ame	NULL
sates	NULL
were	NULL
immunoprecipitated	NULL
(	NULL
IP	NULL
)	NULL
with	NULL
_	NULL
lid	NULL
anti-Grf40	NULL
or	NULL
preimmune	NULL
(	NULL
control	NULL
)	NULL
serum	NULL
.	NULL

1B	NULL
:	NULL
arab	NULL
The	NULL
immunoprecipitates	NULL
were	NULL
separated	NULL
by	NULL
``	NULL
a	NULL
E	NULL
-	NULL
Grf40	NULL
SDS-PAGE	NULL
and	NULL
then	NULL
immunoblotted	NULL
(	NULL
IB	NULL
)	NULL
-	NULL
with	NULL
antiphosphotyrosine	NULL
mAbs	NULL
(	NULL
A	NULL
)	NULL
,	NULL
and	NULL
with	NULL
anti-SLP-76	NULL
antiserum	NULL
or	NULL
anti-LAT	NULL
Ab	NULL
(	NULL
B	NULL
)	NULL
.	NULL

COS7	NULL
cells	NULL
were	NULL
transiently	NULL
trans-j	NULL
;	NULL
fected	NULL
with	NULL
10	NULL
jug	NULL
expression	NULL
plasmids	NULL
for	NULL
Stimulat	NULL
B	NULL
&	NULL
mech	NULL
D	NULL
Grf40	NULL
Myc-tagged	NULL
wild-type	NULL
Grf4O0	NULL
(	NULL
wild	NULL
)	NULL
or	NULL
four	NULL
m-	NULL
--	NULL
-4	NULL
vector	NULL
Myc-tagged	NULL
Grf40	NULL
mutants	NULL
(	NULL
dSH3C	NULL
,	NULL
dSH2	NULL
,	NULL
©	NULL
§	NULL
s	NULL
§	NULL
©	NULL
a	NULL
9	NULL
0	NULL
9	NULL
dSH3N	NULL
,	NULL
and	NULL
dSH3NC	NULL
)	NULL
,	NULL
together	NULL
with	NULL
10	NULL
IP	NULL
:	NULL
€	NULL
b	NULL
tE	NULL
6	NULL
2	NULL
B	NULL
E	NULL
E	NULL
2	NULL
1L	NULL
?	NULL

jg	NULL
expression	NULL
plasmids	NULL
for	NULL
SLP-76	NULL
by	NULL
elec-8	NULL
s	NULL
8	NULL
s	NULL
9	NULL
5	NULL
``	NULL
a	NULL
3	NULL
%	NULL
8	NULL
troporation	NULL
,	NULL
and	NULL
then	NULL
incubated	NULL
for	NULL
48	NULL
h.	NULL
or	NULL
-m	NULL
``	NULL
a	NULL
Their	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
1B	NULL
:	NULL
IL|	NULL
IP	NULL
:	NULL
aFlag	NULL
-	NULL
wae	NULL
mik	NULL
«	NULL
e	NULL
-|	NULL
anti-SLP-76	NULL
or	NULL
preimmune	NULL
(	NULL
control	NULL
)	NULL
se-	NULL
[	NULL
IB	NULL
:	NULL
a	NULL
Myc	NULL
rum	NULL
,	NULL
and	NULL
then	NULL
immunoblotted	NULL
with	NULL
anti-|	NULL
*	NULL
___	NULL
w-	NULL
demas	NULL
\-	NULL
Grf40	NULL
Myc	NULL
mAb	NULL
or	NULL
anti-SLP-76	NULL
antiserum	NULL
(	NULL
C	NULL
)	NULL
.	NULL

|	NULL
COS7	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
|_	NULL
same	NULL
!	NULL

-	NULL
<	NULL
LAT	NULL
mak	NULL
-	NULL
wild	NULL
10	NULL
ug	NULL
expression	NULL
plasmids	NULL
for	NULL
Flag-tagged	NULL
iB	NULL
:	NULL
a	NULL
SLP-76	NULL
wild-type	NULL
SLP-76	NULL
(	NULL
wild	NULL
)	NULL
,	NULL
four	NULL
Flag-tagged	NULL
~-	NULL
.	NULL

SLP-76	NULL
mutants	NULL
(	NULL
157-533	NULL
,	NULL
217-533	NULL
,	NULL
241-p	NULL
«	NULL
«	NULL
«	NULL
|	NULL
<	NULL
SLP-76	NULL
IP	NULL
:	NULL
@	NULL
Flag	NULL
ates	NULL
533	NULL
,	NULL
and	NULL
281-533	NULL
)	NULL
,	NULL
or	NULL
an	NULL
empty	NULL
vector	NULL
®	NULL
|	NULL
IB	NULL
:	NULL
«	NULL
Flag	NULL
-	NULL
157-533	NULL
(	NULL
control	NULL
)	NULL
,	NULL
together	NULL
with	NULL
10	NULL
jug	NULL
expression	NULL
m	NULL
``	NULL
``	NULL
``	NULL
Ts	NULL
|-	NULL
<	NULL
217-533	NULL
oon	NULL
nod	NULL
wee	NULL
fo	NULL
?	NULL

as	NULL
L.	NULL
came	NULL
R	NULL
troporation	NULL
,	NULL
an	NULL
en	NULL
incubated	NULL
for	NULL
1B	NULL
:	NULL
a	NULL
Grf4o	NULL
Their	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
-	NULL
281-533	NULL
anti-Flag	NULL
mAb	NULL
,	NULL
and	NULL
then	NULL
immunoblotted	NULL
a	NULL
»	NULL
__	NULL
«	NULL
mm	NULL
)	NULL
<	NULL
=Gif10	NULL
1386	NULL
with	NULL
anti-Myc	NULL
or	NULL
anti-Flag	NULL
mAb	NULL
(	NULL
D	NULL
)	NULL
.	NULL

Grf40	NULL
Involved	NULL
in	NULL
T	NULL
Cell	NULL
Signaling	NULL
(	NULL
GrfAdO0-dSH2	NULL
)	NULL
.	NULL

The	NULL
transfected	NULL
CO	NULL
S7	NULL
cells	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-SLP-76	NULL
Ab	NULL
or	NULL
anti-	NULL
Mye	NULL
mAb	NULL
,	NULL
and	NULL
then	NULL
immunoblotted	NULL
with	NULL
anti-Myc	NULL
mAb	NULL
or	NULL
anti-SLP-76	NULL
Ab	NULL
.	NULL

Wild-type	NULL
Grf40	NULL
and	NULL
the	NULL
Grf40-dSH2	NULL
and	NULL
Grf10-dSH3N	NULL
mutants	NULL
were	NULL
coimmunoprecipitated	NULL
with	NULL
SLP-76	NULL
,	NULL
but	NULL
the	NULL
Grfi0-dSH3C	NULL
and	NULL
Grf10-dSH3NC	NULL
mutants	NULL
were	NULL
not	NULL
tested	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
C	NULL
)	NULL
.	NULL

Conversely	NULL
,	NULL
SLP-76	NULL
was	NULL
coimmunoprecipitated	NULL
with	NULL
Grf40O-dSH2	NULL
,	NULL
Grf40O-dSH3N	NULL
,	NULL
and	NULL
wild-type	NULL
Grf4O0	NULL
,	NULL
but	NULL
not	NULL
with	NULL
Grf40-dSH3C	NULL
and	NULL
Grf40-dSH3NC	NULL
mutants	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
COOH-terminal	NULL
SH3	NULL
domain	NULL
of	NULL
Grf40	NULL
is	NULL
an	NULL
association	NULL
site	NULL
for	NULL
SLP-76	NULL
.	NULL

We	NULL
next	NULL
determined	NULL
the	NULL
association	NULL
site	NULL
of	NULL
SLP-76	NULL
for	NULL
Grf40	NULL
by	NULL
using	NULL
various	NULL
SLP-76	NULL
mutants	NULL
.	NULL

Flag-tagged	NULL
wild-type	NULL
and	NULL
four	NULL
mutants	NULL
of	NULL
SLP-76	NULL
were	NULL
introduced	NULL
into	NULL
CO	NULL
S7	NULL
cells	NULL
together	NULL
with	NULL
Myc-tagged	NULL
Grf4O0	NULL
,	NULL
and	NULL
then	NULL
immunoprecipitated	NULL
and	NULL
immunoblotted	NULL
with	NULL
anti-Flag	NULL
and	NULL
anti-Myc	NULL
Abs	NULL
.	NULL

Myc-tagged	NULL
Grf40	NULL
was	NULL
coimmunoprecipitated	NULL
with	NULL
the	NULL
SLP-76	NULL
mutants	NULL
consisting	NULL
of	NULL
and	NULL
containing	NULL
the	NULL
amino	NULL
acid	NULL
position	NULL
but	NULL
not	NULL
with	NULL
the	NULL
SLP-76	NULL
mutant	NULL
consisting	NULL
of	NULL
the	NULL
amino	NULL
acid	NULL
position	NULL
Pro**-Pro°	NULL
>	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
Grf40	NULL
binding	NULL
site	NULL
is	NULL
located	NULL
in	NULL
the	NULL
amino	NULL
acid	NULL
position	NULL
Glu®	NULL
``	NULL
``	NULL
-Lys	NULL
``	NULL
*	NULL
``	NULL
of	NULL
SLP-76	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
D	NULL
)	NULL
.	NULL

This	NULL
Grf40	NULL
binding	NULL
site	NULL
of	NULL
SLP-76	NULL
almost	NULL
overlaps	NULL
the	NULL
amino	NULL
acid	NULL
position	NULL
Asn*-Asp	NULL
``	NULL
4	NULL
,	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
the	NULL
Grb2	NULL
binding	NULL
site	NULL
(	NULL
15	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
binding	NULL
site	NULL
of	NULL
Grb2	NULL
for	NULL
LAT	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
Grb2	NULL
,	NULL
which	NULL
is	NULL
thought	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
phosphorylated	NULL
tyrosine	NULL
residue	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Together	NULL
with	NULL
this	NULL
notion	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
LAT	NULL
is	NULL
tyrosine	NULL
phosphorylated	NULL
and	NULL
subsequently	NULL
coimmunoprecipitated	NULL
with	NULL
Grf40	NULL
after	NULL
TCR	NULL
stimulation	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
Grf40	NULL
is	NULL
possibly	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
LAT	NULL
.	NULL

Since	NULL
the	NULL
COOH-terminal	NULL
SH3	NULL
domain	NULL
of	NULL
Grb2	NULL
has	NULL
A	NULL
B	NULL
SLP-76	NULL
1	NULL
0.5	NULL
0.2	NULL
0.1	NULL
0.05	NULL
0	NULL
(	NULL
ug	NULL
)	NULL
Grf40	NULL
25	NULL
25	NULL
2.5	NULL
25	NULL
25	NULL
25	NULL
(	NULL
ug	NULL
)	NULL
Grf40	NULL
Grb2	NULL
25	NULL
25	NULL
25	NULL
2.5	NULL
2.5	NULL
25	NULL
(	NULL
ug	NULL
)	NULL
Grf4Q	NULL
»	NULL
|	NULL
«	NULL
mt	NULL
CHP	NULL
sume	NULL
IP	NULL
:	NULL
a	NULL
Flag	NULL
IB	NULL
:	NULL
a	NULL
Myc	NULL
Ig	NULL
5	NULL
-	NULL
waw	NULL
de	NULL
dik	NULL
ats	NULL
Ah	NULL
<	NULL
,	NULL
Grb2	NULL
IP	NULL
:	NULL
a	NULL
Fla	NULL
SLP-76|	NULL
BB	NULL
ame	NULL
«	NULL
»	NULL
I8	NULL
:	NULL
aFiag	NULL
|	NULL
*~	NULL
Grf40	NULL
~	NULL
|	NULL
an	NULL
400	NULL
sme	NULL
«	NULL
o	NULL
.	NULL

24	NULL
~	NULL
m/	NULL
sulle	NULL
ms	NULL
»	NULL
lysates	NULL
IB	NULL
:	NULL
a	NULL
Myc	NULL
Grb2	NULL
»	NULL
@	NULL
»	NULL
@	NULL
B	NULL
gs	NULL
ao	NULL
@	NULL
t	NULL
a-	NULL
»	NULL
«	NULL
1387	NULL
_	NULL
Asada	NULL
et	NULL
al	NULL
.	NULL

Grb2	NULL
0	NULL
1	NULL
2.5	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
SLP-76	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
competitive	NULL
binding	NULL
ability	NULL
between	NULL
Grf40	NULL
and	NULL
Grb2	NULL
to	NULL
SLP-76	NULL
.	NULL

COS7	NULL
cells	NULL
were	NULL
transiently	NULL
trans	NULL
fected	NULL
with	NULL
2.5-pg	NULL
plasmids	NULL
of	NULL
Myc-tagged	NULL
Grf40	NULL
and	NULL
Myc-tagged	NULL
Grb2	NULL
in	NULL
association	NULL
with	NULL
different	NULL
doses	NULL
(	NULL
0-1.0	NULL
g	NULL
)	NULL
of	NULL
Flag-tagged	NULL
SLP-76	NULL
plasmid	NULL
.	NULL

Their	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-Flag	NULL
mAb	NULL
and	NULL
then	NULL
immunoblotted	NULL
with	NULL
anti-	NULL
Myc	NULL
polyclonal	NULL
Ab	NULL
.	NULL

Coimmunoprecipitation	NULL
of	NULL
Myc-tagged	NULL
Grf40	NULL
with	NULL
SLP-76	NULL
gradually	NULL
decreased	NULL
upon	NULL
reducing	NULL
the	NULL
SLP-76	NULL
plasmid	NULL
dose	NULL
to	NULL
0.05	NULL
pg	NULL
,	NULL
whereas	NULL
the	NULL
Myc-tagged	NULL
Grb2	NULL
coimmunoprecipitation	NULL
with	NULL
SLP-76	NULL
was	NULL
detectable	NULL
only	NULL
at	NULL
a	NULL
1.0-pmg	NULL
dose	NULL
of	NULL
SLP-76	NULL
plasmid	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
)	NULL
.	NULL

Expression	NULL
levels	NULL
of	NULL
the	NULL
plasmids	NULL
introduced	NULL
were	NULL
quantified	NULL
by	NULL
immunoblotting	NULL
,	NULL
confirming	NULL
that	NULL
there	NULL
was	NULL
no	NULL
significant	NULL
difference	NULL
in	NULL
the	NULL
amounts	NULL
between	NULL
Myc-tagged	NULL
Grf40	NULL
and	NULL
Myc-tagged	NULL
Grb2	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
the	NULL
possibility	NULL
that	NULL
Grf4O0	NULL
associated	NULL
much	NULL
stronger	NULL
with	NULL
SLP-76	NULL
than	NULL
did	NULL
Grb2	NULL
.	NULL

To	NULL
confirm	NULL
this	NULL
fur-ther	NULL
,	NULL
COS7	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
low	NULL
doses	NULL
of	NULL
SLP-76	NULL
plasmid	NULL
(	NULL
0.2	NULL
ug	NULL
)	NULL
and	NULL
Myc-Grf40	NULL
plasmid	NULL
(	NULL
2.5	NULL
wg	NULL
)	NULL
together	NULL
with	NULL
various	NULL
doses	NULL
(	NULL
0-10	NULL
pg	NULL
)	NULL
of	NULL
Myc-tagged	NULL
Grb2	NULL
plasmid	NULL
.	NULL

Their	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-Flag	NULL
mAb	NULL
and	NULL
then	NULL
immunoblotted	NULL
with	NULL
anti-	NULL
Myc	NULL
polyclonal	NULL
Ab	NULL
.	NULL

Even	NULL
when	NULL
up	NULL
to	NULL
10-	NULL
wg	NULL
plasmid	NULL
doses	NULL
of	NULL
Myc-tagged	NULL
Grb2	NULL
were	NULL
cotransfected	NULL
,	NULL
coimmunoprecipitation	NULL
of	NULL
Myc-tagged	NULL
Grf4d0	NULL
with	NULL
SLP-76	NULL
was	NULL
still	NULL
unchanged	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
B	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
although	NULL
the	NULL
increased	NULL
expression	NULL
of	NULL
Myc-tagged	NULL
Grb2	NULL
was	NULL
dependent	NULL
on	NULL
its	NULL
plas	NULL
mid	NULL
dose	NULL
,	NULL
which	NULL
was	NULL
considerably	NULL
higher	NULL
than	NULL
that	NULL
of	NULL
Grf10	NULL
at	NULL
a	NULL
10-	NULL
ppg	NULL
plasmid	NULL
dose	NULL
of	NULL
Myc-tagged	NULL
Grb2	NULL
,	NULL
Myc-tagged	NULL
Grb2	NULL
was	NULL
not	NULL
coimmunoprecipitated	NULL
with	NULL
SLP-76	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
Grf40	NULL
competes	NULL
with	NULL
Grb2	NULL
in	NULL
its	NULL
binding	NULL
to	NULL
SLP-76	NULL
,	NULL
and	NULL
the	NULL
binding	NULL
affinity	NULL
of	NULL
Grf10	NULL
to	NULL
SLP-76	NULL
0.2	NULL
0.2	NULL
0.2	NULL
0.2	NULL
0.2	NULL
(	NULL
ng	NULL
)	NULL
25	NULL
25	NULL
2.5	NULL
2.5	NULL
2.5	NULL
(	NULL
ug	NULL
)	NULL
5	NULL
10	NULL
(	NULL
ug	NULL
)	NULL
asp	NULL
cao	NULL
«	NULL
p	NULL
«	NULL
«	NULL
»	NULL
camp	NULL
-a	NULL
(	NULL
;	NULL
[	NULL
)	NULL
Figure	NULL
3	NULL
.	NULL

Competitive	NULL
binding	NULL
ability	NULL
of	NULL
Grf40	NULL
and	NULL
Grb2	NULL
to	NULL
SLP-76	NULL
.	NULL

COST	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
doses	NULL
of	NULL
pFlagSLP	NULL
(	NULL
SLP-76	NULL
)	NULL
,	NULL
2.5	NULL
ug	NULL
of	NULL
(	NULL
Grf40	NULL
)	NULL
,	NULL
and	NULL
2.5	NULL
jug	NULL
of	NULL
pMycGrb2	NULL
(	NULL
Grb2	NULL
)	NULL
(	NULL
A	NULL
)	NULL
,	NULL
or	NULL
0.2	NULL
ug	NULL
of	NULL
pFlagSLP	NULL
,	NULL
2.5	NULL
jug	NULL
of	NULL
pMycGrf10	NULL
,	NULL
and	NULL
the	NULL
indicated	NULL
doses	NULL
of	NULL
pMycGrb2	NULL
(	NULL
B	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
48	NULL
h	NULL
,	NULL
and	NULL
their	NULL
|	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
(	NULL
IP	NULL
)	NULL
with	NULL
anti-Flag	NULL
mAb	NULL
and	NULL
then	NULL
immunoblotted	NULL
(	NULL
IB	NULL
)	NULL
with	NULL
anti-Myc	NULL
polyclonal	NULL
Ab	NULL
or	NULL
anti-Flag	NULL
mAb	NULL
(	NULL
top	NULL
and	NULL
middle	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
levels	NULL
of	NULL
Myc-tagged	NULL
and	NULL
Myc-tagged	NULL
Grb2	NULL
were	NULL
quantified	NULL
by	NULL
immunoblotting	NULL
with	NULL
anti-Myc	NULL
mAb	NULL
(	NULL
bottom	NULL
)	NULL
.	NULL

«	NULL
-=	NULL
-=	NULL
SLP-76	NULL
Mais	NULL
.	NULL

mes	NULL
:	NULL
-	NULL
Grf40	NULL
«	NULL
»	NULL
U	NULL
»	NULL
-	NULL
Crbz2	NULL
SLP-76	NULL
is	NULL
apparently	NULL
higher	NULL
than	NULL
that	NULL
of	NULL
Grb2	NULL
.	NULL

Since	NULL
the	NULL
SLP-76	NULL
mutant	NULL
deleted	NULL
of	NULL
the	NULL
Grb2	NULL
binding	NULL
site	NULL
,	NULL
which	NULL
overlaps	NULL
the	NULL
Grf40	NULL
binding	NULL
site	NULL
,	NULL
failed	NULL
to	NULL
increase	NULL
IL-2	NULL
promoter	NULL
activity	NULL
upon	NULL
TCR	NULL
stimulation	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
not	NULL
only	NULL
Grb2	NULL
but	NULL
also	NULL
Grf40	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
the	NULL
SLP-76-dependent	NULL
increase	NULL
in	NULL
IL-2	NULL
promoter	NULL
activity	NULL
.	NULL

To	NULL
address	NULL
the	NULL
functional	NULL
significance	NULL
of	NULL
Grf40	NULL
in	NULL
TCR	NULL
mediated	NULL
signaling	NULL
,	NULL
we	NULL
performed	NULL
luciferase	NULL
assays	NULL
with	NULL
reporter	NULL
genes	NULL
containing	NULL
the	NULL
IL-2	NULL
promoter	NULL
and	NULL
the	NULL
NF-	NULL
AT	NULL
binding	NULL
domain	NULL
.	NULL

Overexpression	NULL
of	NULL
wild-type	NULL
Grf40	NULL
did	NULL
not	NULL
lead	NULL
to	NULL
either	NULL
basal	NULL
or	NULL
TCR	NULL
-mediated	NULL
activation	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
and	NULL
NF-AT	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Since	NULL
Grf40	NULL
interacts	NULL
with	NULL
SLP-76	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
and	NULL
overexpression	NULL
of	NULL
SLP-76	NULL
is	NULL
known	NULL
to	NULL
augment	NULL
TCR	NULL
-mediated	NULL
stimulation	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
and	NULL
NF-AT	NULL
activity	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
,	NULL
we	NULL
used	NULL
Jurkat	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
SLP-76	NULL
to	NULL
examine	NULL
the	NULL
effect	NULL
of	NULL
Grf40	NULL
in	NULL
TCR	NULL
-mediated	NULL
signaling	NULL
.	NULL

Transfections	NULL
of	NULL
wild-type	NULL
Grf40	NULL
and	NULL
Grf4O-dSH3N	NULL
mutant	NULL
into	NULL
Jurkat	NULL
cells	NULL
overexpressing	NULL
SLP-76	NULL
led	NULL
to	NULL
significant	NULL
increases	NULL
in	NULL
IL-2	NULL
promoter	NULL
activity	NULL
upon	NULL
stimulation	NULL
with	NULL
OKT	NULL
3	NULL
plus	NULL
PMA	NULL
,	NULL
whereas	NULL
transfection	NULL
of	NULL
Grf40-dSH2	NULL
mutant	NULL
induced	NULL
a	NULL
marked	NULL
inhibition	NULL
of	NULL
IL-2	NULL
promoter	NULL
activity	NULL
compared	NULL
with	NULL
transfection	NULL
of	NULL
an	NULL
empty	NULL
vector	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
Grf40-dSH2	NULL
mutant	NULL
has	NULL
a	NULL
dominant-negative	NULL
effect	NULL
in	NULL
TCR	NULL
stimulation	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
Grf40	NULL
interacts	NULL
with	NULL
an	NULL
essential	NULL
molecule	NULL
for	NULL
TCR	NULL
-mediated	NULL
signaling	NULL
,	NULL
which	NULL
is	NULL
possibly	NULL
LAT	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
NF-AT	NULL
luciferase	NULL
assays	NULL
with	NULL
Jurkat	NULL
cells	NULL
stimulated	NULL
with	NULL
OKT	NULL
3	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
B	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
Grf40	NULL
mutants	NULL
(	NULL
Grfi0-dSH3C	NULL
and	NULL
Grf40-dSH3NC	NULL
)	NULL
deleted	NULL
of	NULL
the	NULL
COOH-terminal	NULL
SH3	NULL
domain	NULL
,	NULL
which	NULL
is	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
SLP-76	NULL
,	NULL
also	NULL
lost	NULL
their	NULL
ability	NULL
to	NULL
increase	NULL
IL-2	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
a	NULL
complex	NULL
formation	NULL
is	NULL
required	NULL
for	NULL
SLP-76-dependent	NULL
TCR	NULL
stimulation	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
Grf40	NULL
is	NULL
involved	NULL
in	NULL
signaling	NULL
the	NULL
stimulation	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
and	NULL
NF-AT	NULL
activities	NULL
mediated	NULL
by	NULL
OKT	NULL
3	NULL
and	NULL
PMA	NULL
.	NULL

Since	NULL
Grb2	NULL
has	NULL
also	NULL
been	NULL
considered	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
modulation	NULL
of	NULL
TCR	NULL
-mediated	NULL
signal	NULL
transduction	NULL
(	NULL
9	NULL
)	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
functional	NULL
significance	NULL
of	NULL
Grf40	NULL
and	NULL
Grb2	NULL
in	NULL
TCR	NULL
-mediated	NULL
stimulation	NULL
of	NULL
IL-2	NULL
promoter	NULL
activity	NULL
.	NULL

Jurkat	NULL
cells	NULL
overexpressing	NULL
SLP-76	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
wild-types	NULL
and	NULL
SH2	NULL
deletion	NULL
mutants	NULL
of	NULL
Grf40	NULL
and	NULL
Grb2	NULL
,	NULL
in	NULL
association	NULL
with	NULL
an	NULL
IL-2	NULL
promoter-driven	NULL
luciferase	NULL
construct	NULL
.	NULL

They	NULL
were	NULL
stimulated	NULL
with	NULL
OKT3	NULL
plus	NULL
PMA	NULL
,	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

An	NULL
appreciable	NULL
enhancement	NULL
of	NULL
IL-2	NULL
promoter	NULL
activity	NULL
was	NULL
seen	NULL
with	NULL
wild-type	NULL
Grf40	NULL
,	NULL
but	NULL
scarcely	NULL
with	NULL
wild-type	NULL
Grb2	NULL
,	NULL
whereas	NULL
Grf40-dSH2	NULL
mutant	NULL
showed	NULL
a	NULL
marked	NULL
dominant-negative	NULL
effect	NULL
in	NULL
the	NULL
IL-2	NULL
luciferase	NULL
assay	NULL
compared	NULL
with	NULL
Grb2-dSH2	NULL
mutant	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
A	NULL
)	NULL
.	NULL

The	NULL
plasmid	NULL
dose	NULL
dependency	NULL
in	NULL
the	NULL
IL-2	NULL
luciferase	NULL
assay	NULL
was	NULL
compared	NULL
between	NULL
the	NULL
Grf4O-dSH2	NULL
and	NULL
Grb2-dSH2	NULL
mutants	NULL
The	NULL
suppressive	NULL
effects	NULL
on	NULL
the	NULL
luciferase	NULL
activities	NULL
were	NULL
significantly	NULL
stronger	NULL
in	NULL
Grf40-dSH2	NULL
mutant	NULL
than	NULL
Grb2-dSH2	NULL
mutant	NULL
at	NULL
various	NULL
plasmid	NULL
doses	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
Grf40	NULL
is	NULL
involved	NULL
in	NULL
TCR	NULL
-mediated	NULL
signaling	NULL
more	NULL
effectively	NULL
than	NULL
Grb2	NULL
.	NULL

This	NULL
conclusion	NULL
is	NULL
in	NULL
accordance	NULL
with	NULL
the	NULL
observation	NULL
of	NULL
greater	NULL
binding	NULL
affinity	NULL
of	NULL
Grf40	NULL
to	NULL
SLP-76	NULL
compared	NULL
with	NULL
Grb2	NULL
.	NULL

This	NULL
study	NULL
showed	NULL
a	NULL
critical	NULL
involvement	NULL
of	NULL
Grf40	NULL
in	NULL
the	NULL
SLP-76-dependent	NULL
signaling	NULL
mediated	NULL
by	NULL
the	NULL
TCR	NULL
.	NULL

One	NULL
might	NULL
consider	NULL
the	NULL
possibility	NULL
that	NULL
Grf40	NULL
mutants	NULL
exert	NULL
their	NULL
effects	NULL
in	NULL
TCR	NULL
-mediated	NULL
signaling	NULL
by	NULL
altering	NULL
expression	NULL
levels	NULL
of	NULL
SLP-76	NULL
.	NULL

However	NULL
,	NULL
this	NULL
possibility	NULL
is	NULL
negligible	NULL
because	NULL
the	NULL
expression	NULL
of	NULL
pCX-SLP76	NULL
was	NULL
confirmed	NULL
to	NULL
be	NULL
unaffected	NULL
by	NULL
transient	NULL
expression	NULL
of	NULL
Grf4O0	NULL
,	NULL
Grb2	NULL
,	NULL
and	NULL
their	NULL
mutants	NULL
in	NULL
CO	NULL
S7	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
the	NULL
interaction	NULL
of	NULL
Grf40	NULL
with	NULL
SLP-76	NULL
and	NULL
LAT	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
TCR	NULL
-mediated	NULL
signaling	NULL
.	NULL

The	NULL
NH	NULL
,	NULL
-terminal	NULL
SH3	NULL
domain	NULL
of	NULL
Grb2	NULL
is	NULL
known	NULL
to	NULL
be	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
Sos	NULL
,	NULL
a	NULL
R	NULL
as	NULL
guanine	NULL
nucleotide	NULL
exchange	NULL
factor	NULL
,	NULL
which	NULL
has	NULL
been	NULL
considered	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
Ras	NULL
activation	NULL
upon	NULL
TCR	NULL
stimulation	NULL
(	NULL
9	NULL
)	NULL
.	NULL

We	NULL
confirmed	NULL
the	NULL
association	NULL
of	NULL
Grb2	NULL
with	NULL
Sos	NULL
in	NULL
Jurkat	NULL
cells	NULL
;	NULL
however	NULL
,	NULL
a	NULL
complex	NULL
formation	NULL
between	NULL
Grf40	NULL
and	NULL
Sos	NULL
was	NULL
undetectable	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
suspect	NULL
>	NULL
50	NULL
-	NULL
m	NULL
B	NULL
I	NULL
10	NULL
B	NULL
.L	NULL
>	NULL
9	NULL
°C	NULL
i	NULL
=	NULL
i	NULL
g	NULL
40-	NULL
E	NULL
2	NULL
t	NULL
8	NULL
a	NULL
8	NULL
3	NULL
f	NULL
<	NULL
§	NULL
£	NULL
&	NULL
m-	NULL
£	NULL
8	NULL
I	NULL
4	NULL
0	NULL
.	NULL

£	NULL
c	NULL
ao	NULL
-	NULL
>	NULL
+I	NULL
§	NULL
m	NULL
=	NULL
54	NULL
-	NULL
20	NULL
-|	NULL
wi	NULL
4	NULL
co	NULL
%	NULL
b	NULL
&	NULL
A	NULL
<	NULL
T	NULL
44	NULL
i	NULL
H	NULL
2	NULL
10	NULL
-	NULL
'	NULL
*	NULL
#	NULL
I	NULL
_E	NULL
hil	NULL
L	NULL
mm	NULL
vector	NULL
wild	NULL
dSH3N	NULL
dSH3C	NULL
dSH3NC	NULL
dSH2	NULL
vector	NULL
wild	NULL
dSH2	NULL
Figure	NULL
4	NULL
.	NULL

-	NULL
Effects	NULL
of	NULL
Grf4O	NULL
mutants	NULL
on	NULL
TCR	NULL
-mediated	NULL
activation	NULL
of	NULL
IL-2	NULL
promoter	NULL
and	NULL
NF-AT	NULL
activities	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
jug	NULL
of	NULL
IL-2-Luc	NULL
(	NULL
A	NULL
)	NULL
or	NULL
10	NULL
jug	NULL
of	NULL
NF-AT-Luc	NULL
(	NULL
B	NULL
)	NULL
,	NULL
along	NULL
with	NULL
10	NULL
pg	NULL
of	NULL
SLP-76	NULL
and	NULL
10	NULL
jug	NULL
of	NULL
an	NULL
empty	NULL
vector	NULL
(	NULL
vector	NULL
)	NULL
,	NULL
Myc-tagged	NULL
wild-type	NULL
GrfO	NULL
(	NULL
wild	NULL
)	NULL
,	NULL
or	NULL
various	NULL
mutants	NULL
(	NULL
dSH3N	NULL
,	NULL
dSH3C	NULL
,	NULL
dSH3NC	NULL
,	NULL
and	NULL
dSH2	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
left	NULL
unstimulated	NULL
(	NULL
white	NULL
bars	NULL
)	NULL
or	NULL
were	NULL
stimulated	NULL
(	NULL
black	NULL
bars	NULL
)	NULL
with	NULL
10	NULL
pg/ml	NULL
OKT	NULL
3	NULL
plus	NULL
50	NULL
ng/	NULL
ml	NULL
PMA	NULL
,	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

R	NULL
esults	NULL
are	NULL
shown	NULL
as	NULL
fold	NULL
induction	NULL
of	NULL
luciferase	NULL
activity	NULL
compared	NULL
with	NULL
the	NULL
activity	NULL
in	NULL
unstimulated	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
(	NULL
~5,000	NULL
relative	NULL
light	NULL
units	NULL
[	NULL
RLU	NULL
]	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
comparable	NULL
experiments	NULL
.	NULL

1388	NULL
Grf40	NULL
Involved	NULL
in	NULL
T	NULL
Cell	NULL
Signaling	NULL
3	NULL
>	NULL
100	NULL
50	NULL
80	NULL
40	NULL
60	NULL
30-	NULL
207	NULL
IL2	NULL
Luciferase	NULL
Activity	NULL
(	NULL
Fold	NULL
Induction	NULL
)	NULL
IL-2	NULL
Luciferase	NULL
Activity	NULL
{	NULL
Fold	NULL
Induction	NULL
)	NULL
vector	NULL
_	NULL
Grf40	NULL
Grf40	NULL
Grb2	NULL
Grb2	NULL
0	NULL
wild	NULL
dSH2	NULL
wild	NULL
dSH2	NULL
--	NULL
-fG	NULL
--	NULL
&	NULL
g	NULL
5	NULL
10	NULL
20	NULL
Plasmid	NULL
dose	NULL
(	NULL
1g	NULL
)	NULL
Figure	NULL
5	NULL
.	NULL

-	NULL
Comparison	NULL
of	NULL
blocking	NULL
effects	NULL
between	NULL
Grf4O0-dSH2	NULL
and	NULL
Grb2-dSH2	NULL
on	NULL
TCR	NULL
-mediated	NULL
stimulation	NULL
of	NULL
IL-2	NULL
promoter	NULL
activity	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
jug	NULL
of	NULL
IL-2-Luc	NULL
along	NULL
with	NULL
10	NULL
pg	NULL
of	NULL
SLP-76	NULL
and	NULL
10	NULL
jpg	NULL
of	NULL
an	NULL
empty	NULL
vector	NULL
(	NULL
vector	NULL
)	NULL
,	NULL
Myc-tagged	NULL
Grf40	NULL
wild-type	NULL
,	NULL
Grf40-dSH2	NULL
,	NULL
Grb2	NULL
wild-type	NULL
,	NULL
or	NULL
Grb2-dSH2	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
left	NULL
unstimulated	NULL
(	NULL
white	NULL
bars	NULL
)	NULL
or	NULL
were	NULL
stimulated	NULL
(	NULL
black	NULL
bars	NULL
)	NULL
with	NULL
OKT	NULL
3	NULL
plus	NULL
PMA	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
g	NULL
of	NULL
IL-2-Luc	NULL
along	NULL
with	NULL
10	NULL
pg	NULL
of	NULL
SLP-76	NULL
and	NULL
the	NULL
indicated	NULL
doses	NULL
of	NULL
Grf40-dSH2	NULL
(	NULL
squares	NULL
)	NULL
or	NULL
Grb2-dSH2	NULL
(	NULL
circles	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
left	NULL
unstimulated	NULL
(	NULL
open	NULL
symbols	NULL
)	NULL
or	NULL
were	NULL
stimulated	NULL
(	NULL
filled	NULL
symbols	NULL
)	NULL
with	NULL
OKT	NULL
3	NULL
plus	NULL
PMA	NULL
,	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
indicated	NULL
as	NULL
average	NULL
fold	NULL
induction	NULL
+	NULL
SE	NULL
from	NULL
three	NULL
independent	NULL
experiments	NULL
compared	NULL
with	NULL
unstimulated	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
(	NULL
~5,000	NULL
RLU	NULL
)	NULL
.	NULL

that	NULL
Grf40	NULL
does	NULL
not	NULL
direct	NULL
the	NULL
R	NULL
as	NULL
activation	NULL
signaling	NULL
mediated	NULL
by	NULL
the	NULL
TCR	NULL
.	NULL

However	NULL
,	NULL
Grf40	NULL
contributes	NULL
to	NULL
TCR	NULL
mediated	NULL
activation	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
and	NULL
NF-AT	NULL
more	NULL
effectively	NULL
than	NULL
Grb2	NULL
,	NULL
suggesting	NULL
the	NULL
critical	NULL
involvement	NULL
of	NULL
Grf40	NULL
in	NULL
TCR	NULL
-mediated	NULL
signaling	NULL
.	NULL

In	NULL
this	NULL
context	NULL
,	NULL
it	NULL
is	NULL
of	NULL
interest	NULL
that	NULL
SLP-76	NULL
associated	NULL
with	NULL
Grf40	NULL
also	NULL
binds	NULL
to	NULL
Vav	NULL
,	NULL
a	NULL
R	NULL
ac/R	NULL
ho	NULL
guanine	NULL
nucleotide	NULL
exchange	NULL
factor	NULL
,	NULL
and	NULL
that	NULL
the	NULL
interaction	NULL
between	NULL
SLP-76	NULL
and	NULL
Vay	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
participate	NULL
in	NULL
IL-2	NULL
gene	NULL
activation	NULL
upon	NULL
TCR	NULL
stimulation	NULL
(	NULL
17	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
provide	NULL
a	NULL
model	NULL
pathway	NULL
in	NULL
which	NULL
activated	NULL
ZAP-70	NULL
tyrosine	NULL
kinase	NULL
after	NULL
TCR	NULL
ligation	NULL
phos	NULL
phorylates	NULL
LAT	NULL
(	NULL
18	NULL
)	NULL
,	NULL
which	NULL
then	NULL
binds	NULL
to	NULL
the	NULL
preformed	NULL
Grfi0O-SLP-76	NULL
complex	NULL
and	NULL
recruits	NULL
it	NULL
to	NULL
ZAP-70	NULL
(	NULL
29	NULL
)	NULL
,	NULL
which	NULL
further	NULL
phosphorylates	NULL
SLP-76	NULL
to	NULL
be	NULL
associated	NULL
with	NULL
Vav	NULL
,	NULL
leading	NULL
to	NULL
the	NULL
downstream	NULL
signaling	NULL
of	NULL
the	NULL
TCR	NULL
.	NULL

Northern	NULL
blot	NULL
and	NULL
immunoblot	NULL
analyses	NULL
revealed	NULL
that	NULL
Grf40	NULL
is	NULL
expressed	NULL
predominantly	NULL
in	NULL
immunotissues	NULL
and	NULL
hematopoietic	NULL
cells	NULL
,	NULL
particularly	NULL
T	NULL
cells	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
Grb2	NULL
.	NULL

Such	NULL
restricted	NULL
distribution	NULL
of	NULL
Grf40	NULL
may	NULL
reflect	NULL
the	NULL
more	NULL
efficient	NULL
involvement	NULL
of	NULL
Grf40	NULL
in	NULL
TCR	NULL
-mediated	NULL
signaling	NULL
compared	NULL
with	NULL
Grb2	NULL
.	NULL

Although	NULL
Grap	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
specific	NULL
for	NULL
hematopoietic	NULL
and	NULL
lymphocytic	NULL
cells	NULL
(	NULL
28	NULL
)	NULL
,	NULL
the	NULL
functional	NULL
significance	NULL
of	NULL
Grap	NULL
is	NULL
still	NULL
unknown	NULL
.	NULL

The	NULL
genome	NULL
sequence	NULL
of	NULL
GR	NULL
B2L	NULL
has	NULL
been	NULL
registered	NULL
in	NULL
GenBank/EMBL/DDBJ	NULL
(	NULL
under	NULL
accession	NULL
no	NULL
.	NULL

282206	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
entire	NULL
sequence	NULL
of	NULL
Since	NULL
GR	NULL
B2L	NULL
has	NULL
been	NULL
mapped	NULL
to	NULL
human	NULL
chromosome	NULL
22q12	NULL
,	NULL
Grf40	NULL
is	NULL
thought	NULL
to	NULL
have	NULL
the	NULL
same	NULL
chromosomal	NULL
location	NULL
.	NULL

Furthermore	NULL
,	NULL
cDNA	NULL
clones	NULL
identical	NULL
to	NULL
Grf40	NULL
were	NULL
reported	NULL
as	NULL
Grap2	NULL
(	NULL
30	NULL
)	NULL
,	NULL
and	NULL
human	NULL
Gads	NULL
(	NULL
31	NULL
)	NULL
and	NULL
their	NULL
mouse	NULL
homo-logues	NULL
,	NULL
named	NULL
Mona	NULL
(	NULL
32	NULL
)	NULL
and	NULL
mouse	NULL
Gads	NULL
(	NULL
33	NULL
)	NULL
,	NULL
were	NULL
also	NULL
reported	NULL
after	NULL
the	NULL
submission	NULL
of	NULL
this	NULL
paper	NULL
.	NULL

Although	NULL
the	NULL
report	NULL
regarding	NULL
human	NULL
Gads	NULL
showed	NULL
similar	NULL
results	NULL
as	NULL
our	NULL
study	NULL
,	NULL
they	NULL
did	NULL
not	NULL
show	NULL
any	NULL
comparative	NULL
study	NULL
between	NULL
Gads	NULL
and	NULL
Grb2	NULL
.	NULL

We	NULL
here	NULL
show	NULL
evidence	NULL
suggesting	NULL
that	NULL
Grf40	NULL
plays	NULL
a	NULL
more	NULL
critical	NULL
role	NULL
in	NULL
the	NULL
TCR	NULL
-mediated	NULL
signaling	NULL
than	NULL
Grb2	NULL
.	NULL

We	NULL
thank	NULL
Dr.	NULL
H.	NULL
Onodera	NULL
for	NULL
providing	NULL
Myc-Tag-peDNA3.1	NULL
(	NULL
+	NULL
)	NULL
,	NULL
and	NULL
Drs	NULL
.	NULL

S.	NULL
Moffatt	NULL
and	NULL
LC	NULL
.	NULL

Ndhlovu	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
Core	NULL
Research	NULL
for	NULL
Evolutional	NULL
Science	NULL
and	NULL
Technology	NULL
(	NULL
CREST	NULL
)	NULL
of	NULL
the	NULL
Japan	NULL
Science	NULL
and	NULL
Technology	NULL
Corporation	NULL
;	NULL
by	NULL
a	NULL
grant-in-aid	NULL
for	NULL
scientific	NULL
research	NULL
on	NULL
priority	NULL
areas	NULL
from	NULL
the	NULL
Ministry	NULL
of	NULL
Education	NULL
,	NULL
Science	NULL
,	NULL
Sport	NULL
,	NULL
and	NULL
Culture	NULL
of	NULL
Japan	NULL
;	NULL
and	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
special	NULL
coordination	NULL
funds	NULL
of	NULL
the	NULL
Science	NULL
and	NULL
Technology	NULL
Agency	NULL
of	NULL
Japan	NULL
.	NULL

Address	NULL
correspondence	NULL
to	NULL
Kazuo	NULL
Sugamura	NULL
,	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
Tohoku	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
2-1	NULL
Seiryo-machi	NULL
,	NULL
Aoba-ku	NULL
,	NULL
Sendai	NULL
980-8575	NULL
,	NULL
Japan	NULL
.	NULL

Phone	NULL
:	NULL
81-22-717-8096	NULL
;	NULL
Fax	NULL
:	NULL
81-22-717-8097	NULL
;	NULL
E-mail	NULL
:	NULL
sugamura	NULL
@	NULL
mail.ce.tohoku.ac.jp	NULL
Received	NULL
for	NULL
publication	NULL
19	NULL
Oaober	NULL
1998	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
1	NULL
March	NULL
1999	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Weiss	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
D.R	NULL
.	NULL

Littman	NULL
.	NULL

1994	NULL
.	NULL

Signal	NULL
transduction	NULL
by	NULL
lymphocyte	NULL
antigen	NULL
receptors	NULL
.	NULL

Cell	NULL
.	NULL

76:263-274	NULL
.	NULL

1389	NULL
_	NULL
Asada	NULL
et	NULL
al	NULL
.	NULL

2	NULL
.	NULL

Cantrell	NULL
,	NULL
D.	NULL
1996	NULL
.	NULL

T	NULL
cell	NULL
antigen	NULL
receptor	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:259-274	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19.	NULL
.	NULL

Wange	NULL
,	NULL
RL	NULL
.	NULL

,	NULL
and	NULL
LE	NULL
.	NULL

Samelson	NULL
.	NULL

1996	NULL
.	NULL

Complex	NULL
com	NULL
plexes	NULL
:	NULL
signaling	NULL
at	NULL
the	NULL
TCR	NULL
.	NULL

Immunity	NULL
.	NULL

5:197-205.	NULL
.	NULL

Koretzky	NULL
,	NULL
G.A	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
role	NULL
of	NULL
Grb2-associated	NULL
proteins	NULL
in	NULL
T-cell	NULL
activation	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
.	NULL

18:401-406.	NULL
.	NULL

Sigh	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Batzer	NULL
,	NULL
J.	NULL
Schlessinger	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
1994	NULL
.	NULL

GR	NULL
B2	NULL
and	NULL
phospholipase	NULL
C-gamma	NULL
1	NULL
associate	NULL
with	NULL
a	NULL
36-	NULL
to	NULL
38-kilodalton	NULL
phosphotyrosine	NULL
protein	NULL
after	NULL
T-cell	NULL
receptor	NULL
stimulation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:4435-4442.	NULL
.	NULL

Motto	NULL
,	NULL
D.G	NULL
.	NULL

,	NULL
M.A	NULL
.	NULL

Musci	NULL
,	NULL
SE	NULL
.	NULL

Ross	NULL
,	NULL
and	NULL
G.A	NULL
.	NULL

Koretzky	NULL
.	NULL

1996	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
Grb2-associated	NULL
proteins	NULL
correlates	NULL
with	NULL
phospholipase	NULL
C	NULL
gamma	NULL
1	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
Mol	NULL
.	NULL

Cel	NULL
.	NULL

Biol	NULL
.	NULL

16:2823-2829.	NULL
.	NULL

Lowenstein	NULL
,	NULL
E.J	NULL
.	NULL

,	NULL
R	NULL
.J	NULL
.	NULL

Daly	NULL
,	NULL
A.G.	NULL
Batzer	NULL
,	NULL
W.	NULL
Li	NULL
,	NULL
B.	NULL
Margolis	NULL
,	NULL
R.	NULL
Lammers	NULL
,	NULL
A.	NULL
Ullrich	NULL
,	NULL
EY	NULL
.	NULL

Skolnik	NULL
,	NULL
D.	NULL
Bar-Sagi	NULL
,	NULL
and	NULL
J.	NULL
Schlessinger	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
SH2	NULL
and	NULL
SH3	NULL
domain-containing	NULL
protein	NULL
GR	NULL
B2	NULL
links	NULL
receptor	NULL
tyrosine	NULL
kinases	NULL
to	NULL
ras	NULL
signaling	NULL
.	NULL

Cell	NULL
.	NULL

70:431-442.	NULL
.	NULL

Egan	NULL
,	NULL
S.E	NULL
.	NULL

,	NULL
BW	NULL
.	NULL

Giddings	NULL
,	NULL
M.W	NULL
.	NULL

Brooks	NULL
,	NULL
L.	NULL
Buday	NULL
,	NULL
A.M.	NULL
Sizeland	NULL
,	NULL
and	NULL
R.A.	NULL
Weinberg	NULL
.	NULL

1993	NULL
.	NULL

Association	NULL
of	NULL
Sos	NULL
R	NULL
as	NULL
exchange	NULL
protein	NULL
with	NULL
Grb2	NULL
is	NULL
implicated	NULL
in	NULL
tyrosine	NULL
kinase	NULL
signal	NULL
transduction	NULL
and	NULL
transformation	NULL
.	NULL

Nature	NULL
363:45-51.	NULL
.	NULL

Buday	NULL
,	NULL
L.	NULL
,	NULL
SE	NULL
.	NULL

Egan	NULL
,	NULL
P.	NULL
Rodriguez	NULL
Viciana	NULL
,	NULL
D.A	NULL
.	NULL

Cantrell	NULL
,	NULL
and	NULL
J	NULL
.	NULL

Downward	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
complex	NULL
of	NULL
Grb2	NULL
adaptor	NULL
protein	NULL
,	NULL
Sos	NULL
exchange	NULL
factor	NULL
,	NULL
and	NULL
a	NULL
36-kDa	NULL
membrane-bound	NULL
tyrosine	NULL
phosphoprotein	NULL
is	NULL
implicated	NULL
in	NULL
ras	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

269:9019-9023	NULL
.	NULL

Reif	NULL
,	NULL
K.	NULL
,	NULL
L.	NULL
Buday	NULL
,	NULL
J	NULL
.	NULL

Downward	NULL
,	NULL
and	NULL
D.A	NULL
.	NULL

Cantrell	NULL
.	NULL

1994	NULL
.	NULL

SH3	NULL
domains	NULL
of	NULL
the	NULL
adapter	NULL
molecule	NULL
Grb2	NULL
complex	NULL
with	NULL
two	NULL
proteins	NULL
in	NULL
T	NULL
cells	NULL
:	NULL
the	NULL
guanine	NULL
nucleotide	NULL
exchange	NULL
protein	NULL
Sos	NULL
and	NULL
a	NULL
75-kDa	NULL
protein	NULL
that	NULL
is	NULL
a	NULL
substrate	NULL
for	NULL
T	NULL
cell	NULL
antigen	NULL
receptor-activated	NULL
tyrosine	NULL
kinases	NULL
J	NULL
Bio	NULL
.	NULL

Chen	NULL
.	NULL

269:14081-14087	NULL
.	NULL

Jackman	NULL
,	NULL
JK	NULL
.	NULL

,	NULL
D.G	NULL
.	NULL

Motto	NULL
,	NULL
Q	NULL
.	NULL

Sun	NULL
,	NULL
M.	NULL
Tanemoto	NULL
,	NULL
C.W	NULL
.	NULL

Turck	NULL
,	NULL
G.A	NULL
.	NULL

Peltz	NULL
,	NULL
G.A	NULL
.	NULL

Koretzky	NULL
,	NULL
and	NULL
P.R	NULL
.	NULL

Findell	NULL
.	NULL

1995	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
SLP-76	NULL
,	NULL
a	NULL
76-kDa	NULL
tyrosine	NULL
phosphoprotein	NULL
associated	NULL
with	NULL
Grb2	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
Biol	NULL
Chen	NULL
.	NULL

270:7029-7032	NULL
.	NULL

Wardenburg	NULL
,	NULL
J.B.	NULL
,	NULL
C.	NULL
Fu	NULL
,	NULL
JK	NULL
.	NULL

Jackman	NULL
,	NULL
H.	NULL
Flotow	NULL
,	NULL
S.E	NULL
.	NULL

Wilkinson	NULL
,	NULL
D.H.	NULL
Williams	NULL
,	NULL
R.	NULL
Johnson	NULL
,	NULL
G.	NULL
Kong	NULL
,	NULL
A.C.	NULL
Chan	NULL
,	NULL
and	NULL
P.R	NULL
.	NULL

Findell	NULL
.	NULL

1996	NULL
.	NULL

Phosphorylation	NULL
of	NULL
SLP-76	NULL
by	NULL
the	NULL
ZAP-70	NULL
protein-tyrosine	NULL
kinase	NULL
is	NULL
required	NULL
for	NULL
T-cell	NULL
receptor	NULL
function	NULL
.	NULL

J	NULL
Biol	NULL
Chen	NULL
.	NULL

271:19641-19644	NULL
.	NULL

Clements	NULL
,	NULL
JL	NULL
.	NULL

,	NULL
B.	NULL
Yang	NULL
,	NULL
S.E	NULL
.	NULL

Ross-Barta	NULL
,	NULL
S.L	NULL
.	NULL

Eliason	NULL
,	NULL
R.F	NULL
.	NULL

Hrstka	NULL
,	NULL
R.A.	NULL
Williamson	NULL
,	NULL
and	NULL
G.A	NULL
.	NULL

Koretzky	NULL
.	NULL

1998	NULL
.	NULL

Requirement	NULL
for	NULL
the	NULL
leukocyte-specific	NULL
adapter	NULL
protein	NULL
SLP-76	NULL
for	NULL
normal	NULL
T	NULL
cell	NULL
development	NULL
.	NULL

Sdene	NULL
.	NULL

281:416-419	NULL
.	NULL

Yablonski	NULL
,	NULL
D.	NULL
,	NULL
M.R	NULL
.	NULL

Kuhne	NULL
,	NULL
T.	NULL
Kadlecek	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1998	NULL
.	NULL

Uncoupling	NULL
of	NULL
nonreceptor	NULL
tyrosine	NULL
kinases	NULL
from	NULL
PLC-gammal	NULL
in	NULL
an	NULL
SLP-76-deficient	NULL
T	NULL
cell	NULL
.	NULL

Scere	NULL
281:413-416	NULL
.	NULL

Motto	NULL
,	NULL
D.G	NULL
.	NULL

,	NULL
S.E	NULL
.	NULL

Ross	NULL
,	NULL
J.	NULL
Wu	NULL
,	NULL
LR	NULL
.	NULL

Hendricks-Taylor	NULL
,	NULL
and	NULL
G.A	NULL
.	NULL

Koretzky	NULL
.	NULL

1996	NULL
.	NULL

Implication	NULL
of	NULL
the	NULL
GR	NULL
B2-associated	NULL
phosphoprotein	NULL
SLP-76	NULL
in	NULL
T	NULL
cell	NULL
receptor-mediated	NULL
interleukin	NULL
2	NULL
production	NULL
.	NULL

J	NULL
Exp	NULL
.	NULL

Med	NULL
183:1937-1943	NULL
.	NULL

Musci	NULL
,	NULL
M.A	NULL
.	NULL

,	NULL
D.G	NULL
.	NULL

Motto	NULL
,	NULL
SE	NULL
.	NULL

Ross	NULL
,	NULL
N.	NULL
Fang	NULL
,	NULL
and	NULL
G.A	NULL
.	NULL

Koretzky	NULL
.	NULL

1997	NULL
.	NULL

Three	NULL
domains	NULL
of	NULL
SLP-76	NULL
are	NULL
required	NULL
for	NULL
its	NULL
optimal	NULL
function	NULL
in	NULL
a	NULL
T	NULL
cell	NULL
line	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

159:1639-1647	NULL
.	NULL

Wu	NULL
,	NULL
J.	NULL
,	NULL
D.G	NULL
.	NULL

Motto	NULL
,	NULL
G.A	NULL
.	NULL

Koretzky	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
1996	NULL
.	NULL

Vav	NULL
and	NULL
SLP-76	NULL
interact	NULL
and	NULL
functionally	NULL
cooperate	NULL
in	NULL
IL-2	NULL
gene	NULL
activation	NULL
.	NULL

Immunity	NULL
.	NULL

4:593-602	NULL
.	NULL

Zhang	NULL
,	NULL
W.	NULL
,	NULL
J.	NULL
Sloan-Lancaster	NULL
,	NULL
J	NULL
.	NULL

Kitchen	NULL
,	NULL
R	NULL
.P	NULL
.	NULL

Trible	NULL
,	NULL
and	NULL
LE	NULL
.	NULL

Samelson	NULL
.	NULL

1998	NULL
.	NULL

LAT	NULL
:	NULL
the	NULL
ZAP-70	NULL
tyrosine	NULL
kinase	NULL
substrate	NULL
that	NULL
links	NULL
T	NULL
cell	NULL
receptor	NULL
to	NULL
cellular	NULL
activation	NULL
.	NULL

Cal	NULL
92:83-92	NULL
.	NULL

Niwa	NULL
,	NULL
H.	NULL
,	NULL
K.	NULL
Yamamura	NULL
,	NULL
and	NULL
J.	NULL
Miyazaki	NULL
.	NULL

1991	NULL
.	NULL

Efficient	NULL
selection	NULL
for	NULL
high-expression	NULL
transfectants	NULL
with	NULL
a	NULL
novel	NULL
eukary-	NULL
1390	NULL
20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33.	NULL
otic	NULL
vector	NULL
.	NULL

Gare	NULL
108:193-199	NULL
.	NULL

Northrop	NULL
,	NULL
JP	NULL
.	NULL

,	NULL
K.S	NULL
.	NULL

Ullman	NULL
,	NULL
and	NULL
G.R	NULL
.	NULL

Crabtree	NULL
.	NULL

1993	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
components	NULL
of	NULL
the	NULL
lymphoid-specific	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NF-AT	NULL
)	NULL
complex	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

268:2917-2923	NULL
.	NULL

Lee	NULL
,	NULL
H.J	NULL
.	NULL

,	NULL
N.	NULL
Koyano-Nakagawa	NULL
,	NULL
Y.	NULL
Naito	NULL
,	NULL
J.	NULL
Nishida	NULL
,	NULL
N.	NULL
Arai	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
T.	NULL
Yokota	NULL
.	NULL

1993.	NULL
cAMP	NULL
activates	NULL
the	NULL
IL-5	NULL
promoter	NULL
synergistically	NULL
with	NULL
phorbol	NULL
ester	NULL
through	NULL
the	NULL
signaling	NULL
pathway	NULL
involving	NULL
protein	NULL
kinase	NULL
A	NULL
in	NULL
mouse	NULL
thy-moma	NULL
line	NULL
EL-4	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

151:6135-6142	NULL
.	NULL

Ohbo	NULL
,	NULL
K.	NULL
,	NULL
N.	NULL
Takasawa	NULL
,	NULL
N.	NULL
Ishii	NULL
,	NULL
N.	NULL
Tanaka	NULL
,	NULL
M.	NULL
Nakamura	NULL
,	NULL
and	NULL
K.	NULL
Sugamura	NULL
.	NULL

1995	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
interleukin	NULL
2	NULL
receptor	NULL
gamma	NULL
chain	NULL
gene	NULL
promoter	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

270:7479-1486	NULL
.	NULL

Asao	NULL
,	NULL
H.	NULL
,	NULL
Y.	NULL
Sasaki	NULL
,	NULL
T.	NULL
Arita	NULL
,	NULL
N.	NULL
Tanaka	NULL
,	NULL
K.	NULL
Endo	NULL
,	NULL
H.	NULL
Kasai	NULL
,	NULL
T.	NULL
Takeshita	NULL
,	NULL
Y.	NULL
Endo	NULL
,	NULL
T.	NULL
Fujita	NULL
,	NULL
and	NULL
K.	NULL
Sugamura	NULL
.	NULL

1997	NULL
.	NULL

Hrs	NULL
is	NULL
associated	NULL
with	NULL
STAM	NULL
,	NULL
a	NULL
signal-transducing	NULL
adaptor	NULL
molecule	NULL
.	NULL

Its	NULL
suppressive	NULL
effect	NULL
on	NULL
cytokine-induced	NULL
cell	NULL
growth	NULL
.	NULL

J	NULL
Bid	NULL
.	NULL

Chem	NULL
.	NULL

272:32785-32791.	NULL
.	NULL

Asao	NULL
,	NULL
H.	NULL
,	NULL
T.	NULL
Takesita	NULL
,	NULL
N.	NULL
Ishii	NULL
,	NULL
S.	NULL
Kumaki	NULL
,	NULL
M.	NULL
Nakamura	NULL
,	NULL
and	NULL
K.	NULL
Sugamura	NULL
.	NULL

1993	NULL
.	NULL

Reconstitution	NULL
of	NULL
functional	NULL
interleukin	NULL
2	NULL
receptor	NULL
complexes	NULL
on	NULL
fibroblastoid	NULL
cells	NULL
:	NULL
involvement	NULL
of	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
the	NULL
gamma	NULL
chain	NULL
in	NULL
two	NULL
distinct	NULL
signaling	NULL
pathways	NULL
.	NULL

Proc	NULL
Natl	NULL
.	NULL

Aad	NULL
.	NULL

Sa	NULL
.	NULL

USA	NULL
.	NULL

90:4127-4131	NULL
.	NULL

Tanaka	NULL
,	NULL
N.	NULL
,	NULL
H.	NULL
Abe	NULL
,	NULL
H.	NULL
Yagita	NULL
,	NULL
K.	NULL
Okumura	NULL
,	NULL
M.	NULL
Nakamura	NULL
,	NULL
and	NULL
K.	NULL
Sugamura	NULL
.	NULL

1997	NULL
.	NULL

Itk	NULL
,	NULL
a	NULL
T	NULL
cell-specific	NULL
tyrosine	NULL
kinase	NULL
,	NULL
is	NULL
required	NULL
for	NULL
CD2-mediated	NULL
interleukin-2	NULL
promoter	NULL
activation	NULL
in	NULL
the	NULL
human	NULL
T	NULL
cell	NULL
line	NULL
Jurkat	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
.	NULL

27:834-841	NULL
.	NULL

Takeshita	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Arita	NULL
,	NULL
M.	NULL
Higuchi	NULL
,	NULL
H.	NULL
Asao	NULL
,	NULL
K.	NULL
Endo	NULL
,	NULL
H.	NULL
Kuroda	NULL
,	NULL
N.	NULL
Tanaka	NULL
,	NULL
K.	NULL
Murata	NULL
,	NULL
N.	NULL
Ishii	NULL
,	NULL
and	NULL
K.	NULL
Sugamura	NULL
.	NULL

1997	NULL
.	NULL

ST	NULL
AM	NULL
,	NULL
signal	NULL
transducing	NULL
adaptor	NULL
molecule	NULL
,	NULL
is	NULL
associated	NULL
with	NULL
Janus	NULL
kinases	NULL
and	NULL
involved	NULL
in	NULL
signaling	NULL
for	NULL
cell	NULL
growth	NULL
and	NULL
c-myc	NULL
induction	NULL
.	NULL

Immunity	NULL
.	NULL

6:449-457	NULL
.	NULL

Feng	NULL
,	NULL
G.S	NULL
.	NULL

,	NULL
Y.B	NULL
.	NULL

Ouyang	NULL
,	NULL
D.P	NULL
.	NULL

Hu	NULL
,	NULL
Z.Q	NULL
.	NULL

Shi	NULL
,	NULL
R.	NULL
Gentz	NULL
,	NULL
and	NULL
J.	NULL
Ni	NULL
.	NULL

1996	NULL
.	NULL

Grap	NULL
is	NULL
a	NULL
novel	NULL
SH3-SH2-SH3	NULL
adaptor	NULL
protein	NULL
that	NULL
couples	NULL
tyrosine	NULL
kinases	NULL
to	NULL
the	NULL
Ras	NULL
pathway	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

271:12129-12132	NULL
.	NULL

Trub	NULL
,	NULL
T.	NULL
,	NULL
J.D	NULL
.	NULL

Frantz	NULL
,	NULL
M.	NULL
Miyazaki	NULL
,	NULL
H.	NULL
Band	NULL
,	NULL
and	NULL
SE	NULL
.	NULL

Shoelson	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
role	NULL
of	NULL
a	NULL
lymphoid-restricted	NULL
,	NULL
Grb2-like	NULL
SH3-SH2-SH3	NULL
protein	NULL
in	NULL
T	NULL
cell	NULL
receptor	NULL
signaling	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

272:894-902	NULL
.	NULL

Zhang	NULL
,	NULL
W.	NULL
,	NULL
R.P	NULL
.	NULL

Trible	NULL
,	NULL
and	NULL
LE	NULL
.	NULL

Samelson	NULL
.	NULL

1998	NULL
.	NULL

LAT	NULL
palmitoylation	NULL
:	NULL
its	NULL
essential	NULL
role	NULL
in	NULL
membrane	NULL
microdomain	NULL
targeting	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
during	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Immunity	NULL
.	NULL

9:239-246	NULL
.	NULL

Qiu	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
Hua	NULL
,	NULL
M.	NULL
Agrawal	NULL
,	NULL
G.	NULL
Li	NULL
,	NULL
J.	NULL
Cai	NULL
,	NULL
E.	NULL
Chan	NULL
,	NULL
H.	NULL
Zhou	NULL
,	NULL
Y.	NULL
Luo	NULL
,	NULL
and	NULL
M.	NULL
Liu	NULL
.	NULL

1998	NULL
.	NULL

Molecular	NULL
cloning	NULL
and	NULL
expression	NULL
of	NULL
human	NULL
grap-2	NULL
,	NULL
a	NULL
novel	NULL
leukocyte-specific	NULL
SH2-and	NULL
SH3-containing	NULL
adaptor-like	NULL
protein	NULL
that	NULL
binds	NULL
to	NULL
gab-1	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

253:443-447	NULL
.	NULL

Liu	NULL
,	NULL
SK	NULL
.	NULL

,	NULL
N.	NULL
Fang	NULL
,	NULL
G.A	NULL
.	NULL

Koretzky	NULL
,	NULL
and	NULL
C.J	NULL
.	NULL

McGlade	NULL
.	NULL

1999	NULL
.	NULL

The	NULL
hematopoietic-	NULL
specific	NULL
adaptor	NULL
protein	NULL
Gads	NULL
functions	NULL
in	NULL
T-cell	NULL
signaling	NULL
via	NULL
interactions	NULL
with	NULL
the	NULL
SLP-76	NULL
and	NULL
LAT	NULL
adaptors	NULL
.	NULL

Cur	NULL
:	NULL
Biol	NULL
.	NULL

9:67-75	NULL
.	NULL

Bourette	NULL
,	NULL
RP	NULL
.	NULL

,	NULL
S.	NULL
Arnaud	NULL
,	NULL
G.M	NULL
.	NULL

Myles	NULL
,	NULL
J.P.	NULL
Blanchet	NULL
,	NULL
LR	NULL
.	NULL

Rohrschneider	NULL
,	NULL
and	NULL
G.	NULL
Mouchiroud	NULL
.	NULL

1998	NULL
.	NULL

Mona	NULL
,	NULL
a	NULL
novel	NULL
hematopoietic-specific	NULL
adaptor	NULL
interacting	NULL
with	NULL
the	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
receptor	NULL
,	NULL
is	NULL
implicated	NULL
in	NULL
monocyte/	NULL
macrophage	NULL
development	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

17:7273-7281	NULL
.	NULL

Liu	NULL
,	NULL
SK	NULL
.	NULL

,	NULL
and	NULL
C.J	NULL
.	NULL

McGlade	NULL
.	NULL

1998	NULL
.	NULL

Gads	NULL
is	NULL
a	NULL
novel	NULL
SH2	NULL
and	NULL
SH3	NULL
domain-containing	NULL
adaptor	NULL
protein	NULL
that	NULL
binds	NULL
to	NULL
tyro-sine-	NULL
phosphorylated	NULL
Shc	NULL
.	NULL

Oncogene	NULL
.	NULL

17:3073-3082	NULL
.	NULL

Grf40	NULL
Involved	NULL
in	NULL
T	NULL
Cell	NULL
Signaling	NULL

